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T7 RNA polymerase is a single protein capable of driving transcription from a 
simple promoter in virtually any context.  This has made it a powerful tool in a range of 
biotechnology applications.  In this work, previous efforts to evolve or engineer T7 RNA 
polymerase are reviewed.  This work is then expanded upon, first with the development 
of a method for the cell-free evolution of T7 RNA polymerase based on the functioning 
of an autogene.  The autogene is a transcriptional feedback circuit in which active T7 
RNA polymerase proteins transcribe their own gene, resulting in exponential 
amplification of their genetic information.  While this system is doomed by an error 
catastrophe, this can be delayed by the use of in vitro compartmentalization.  In response 
to the limits of the autogene, a novel directed evolution approach termed 
compartmentalized partnered replication (CPR) is presented.   CPR couples the in vivo 
functionality of a gene to its subsequent in vitro amplification by emulsion PCR.  The use 
of CPR to generate a panel of six versions of T7 RNA polymerase, each specific to one of 
six promoters, is described.  Separately, a rational engineering approach, taken to 
facilitate the high-yield transcription of fully 2′-modified RNA, is detailed.  Two sets of 
mutations to T7 RNA polymerase, previously known to confer thermal stability and 
enhance promoter clearance respectively, can be used to enhance the activity of existing 
T7 RNA polymerase mutants that utilize non-standard nucleotides as their substrates.  
 vii 
Next, CPR and random mutagenesis is used to populate the functional fitness landscape 
of T7 RNA polymerase.  This neutral drift library is then challenged to increase the 
processivity of T7 RNA polymerase, enabling long-range transcription.  Finally, the 
lessons that can be learned about T7 RNA polymerase specifically and molecular 
evolution and protein engineering generally are discussed.      
 viii 
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Chapter 1:  T7 RNA polymerase: biological context, use in 
biotechnology, and previous engineering and directed evolution efforts 
The T7 phage-encoded RNA polymerase (T7 RNA polymerase) is a 98-kilodalton 
(883 amino acid) protein capable of recognizing a short 17-base pair promoter with high 
specificity and subsequently initiating transcription de novo (Chamberlin et al., 1970; 
Studier and Moffatt, 1986).  In contrast to most known RNA polymerases, phage-
encoded polymerases comprise a single subunit.  The relative simplicity of T7 RNA 
polymerase has made it suitable as a model for the mechanism of transcription.  It 
functions well in prokaryotic (Studier and Moffatt, 1986; Conrad et al., 1996; Gamer et 
al., 2009) and eukaryotic contexts (Fuerst et al., 1986; Elroy-Stein and Moss, 1990; 
McBride et al., 1994; Wirtz et al., 1998; Tokmakov et al., 2006; Davidson et al., 2012) 
and it does not appear to interact with host machinery or promoters.  It requires no 
additional proteins or cofactors to function in vitro (Schenborn and Mierendorf, 1985; 
Milligan et al., 1987).  These qualities have contributed to it being the workhorse of 
nucleic acid research and protein overexpression and the subject of numerous engineering 
efforts.   
T7 RNA POLYMERASE BIOLOGICAL CONTEXT 
T7 RNA polymerase in the bacteriophage life cycle 
The T7 bacteriophage is a linear, double-stranded DNA phage about 40 kilobases 
in length enclosed in a polyhedral capsid (Krüger and Schroeder, 1981; Dunn and 
Studier, 1983). The tail adsorbs to the bacterial host and the genome is injected through 
the tail into the host.  Shortly thereafter, gene 1 is expressed using host machinery to 
produce T7 RNA polymerase (Studier, 1972).  T7 RNA polymerase then recognizes 17 
distinct 17 base pair promoters, from which it initiates de novo transcription (Krüger and 
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Schroeder, 1981; Bull et al., 2007). This facilitates the expression of all middle and late 
phase genes, allowing phage propagation (Zhang and Studier, 1995). 
T7 RNA polymerase structure and mechanism 
T7 RNA polymerase is structurally related to family A DNA polymerase (e.g. the 
Klenow Fragment and HIV reverse transcriptase) (Zhang and Studier, 1995; Sousa, 1996; 
Kochetkov et al., 1998).  Like other such nucleic acid polymerases, T7 RNA polymerase 
resembles a right hand with domains called the palm, thumb, and fingers as well as a 
large N-terminal domain (Sousa et al., 1993; Steitz et al., 1994; Jeruzalmi and Steitz, 
1998; Cheetham et al., 1999). (Figure 1-1).   
 
Figure 1-1. The structure of T7 RNA polymerase.   
T7 RNA polymerase catalyzes the polymerization of RNA (gray) in an active site formed 
by the palm (red), fingers (blue), and thumb (green) domains.  The N-terminal (yellow) 
and fingers (blue) domains interact with the promoter (gray).  This figure is based on the 
crystal structure of T7 RNA polymerase in the initiation phase, PBD accession number 
1QLN (Cheetham and Steitz, 1999). 
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The first step in transcription is the binding of the promoter and the formation of 
the closed complex (Kochetkov et al., 1998).  This is accomplished by three distinct 
protein-DNA interactions (Cheetham and Steitz, 1999) (Figure 1-2).  The AT-rich region 
from -17 to -13 of the promoter is contacted in the minor groove by residues 85 to 106 of 
the N-terminal domain.  The -4 to +3 region of the promoter is contacted and the double 
helix is melted by residues 230 to 243 of the N-terminal domain.  These regions are less 
important to the high degree of promoter specificity observed in T7 RNA polymerase.  
Promoter substitutions in these regions, especially A to T and T to A mutations, are well 
tolerated (Imburgio et al., 2000).  The primary specificity-determining contacts are made 
by the “specificity loop” (residues 742 to 761 of the fingers domain), specifically by 
interactions made by residues R746, N748, R756, and Q758 with the major groove from -
7 to -11.  Mutations to this part of the promoter usually result in complete loss of 
promoter recognition (Imburgio et al., 2000).  The specific molecular recognition of the 
T7 promoter by T7 RNA polymerase is discussed extensively in Chapter 3.   
 
Figure 1-2. T7 RNA polymerase interaction with the T7 promoter.   
3 loops of T7 RNA polymerase (green) make contacts with the T7 promoter (blue).  This 
figure is based on the crystal structure of T7 RNA polymerase in the initiation phase, 
PBD accession number 1QLN (Cheetham and Steitz, 1999). 
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Upon promoter binding, an N-terminal β-hairpin inserts between the -4 base pair, 
and V237 disrupts hydrogen bonding and facilitates formation of the open promoter 
complex (Cheetham et al., 1999).  The template strand is guided into the active site by 
the base of the specificity loop, and the +1 nucleotide is flipped out by W422, thus 
orienting it toward the incoming +1 GTP.  Natural T7 transcripts are heavily biased 
toward a pppGpG start, likely because the open complex is most stabilized by the strong 
G:C base pairing and purine:purine base stacking in the nascent transcript (Kennedy et 
al., 2007).  This de novo initiation phase of transcription is unstable, often leading to 
abortive cycling, which releases short transcripts fewer than 10 nucleotides in length.  
After this phase, there is a large-scale refolding of the N-terminal domain, eliminating 
contact with promoter, and forming a tunnel for the exit of the nascent transcript (Yin and 
Steitz, 2002).  This moves the polymerase into the elongation phase in which the thumb 
and finger guide the downstream DNA into the active site and allow for processive 
transcription (Tahirov et al., 2002).   
WILD TYPE T7 RNA POLYMERASE USE IN BIOTECHNOLOGY 
T7 RNA polymerase in vivo expression platform 
T7 RNA polymerase elongates five times faster than E. coli RNA polymerase 
(Studier and Moffatt, 1986), and is not impeded by host terminators (McAllister et al., 
1981) or transcriptional polarity (Studier, 1972) allowing it to make predominantly full-
length mRNAs.  Upon induction, mRNA concentrations reach levels comparable to 
ribosomal RNAs, translation machinery becomes saturated, and the target protein can 
account for 50% of the total protein in only a few hours (Studier and Moffatt, 1986).   
The T7 promoter is not recognized by the host’s transcriptional machinery.  This 
means that lethal genes under the control of a T7 promoter can be cloned, provided they 
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are oriented in the opposite direction of the E. coli promoters on the plasmid (Studier and 
Rosenberg, 1981).  It was shown that these silent genes could be activated by the 
infection of T7 phage, which provides T7 RNA polymerase to the cell (McAllister et al., 
1981).  This was proposed as a possible method for controlled overexpression of cloned 
genes in E. coli (McAllister et al., 1981).  However, this proved ineffective because 
transcription from the T7 promoters on the T7 phage genome diverted resources and led 
to lysis of the host (Studier and Moffatt, 1986).  
This limitation was overcome by the cloning of T7 RNA polymerase into a heat 
inducible plasmid (Tabor and Richardson, 1985) and the development of lactose 
inducible systems (Studier and Moffatt, 1986).  A mutant of the λ phage called DE3 was 
created, in which T7 RNA polymerase was placed under the control of the lacUV5 
promoter.  DE3 infection could provide T7 RNA polymerase for expression of target 
genes under the control of the T7 promoter.  For convenience, and to avoid phage-based 
translation inhibition, a stable cell line was created, called BL21(DE3).   BL21(DE3) 
contains a stable DE3 lysogen which provides lactose-inducible T7 RNA polymerase 
(Studier and Moffatt, 1986).  Protein overexpression is now routinely performed with 
IPTG-induced BL21(DE3) cells and the companion pET expression plasmids.   
T7 RNA polymerase is also the basis of many cell-free expression systems, 
including commercially available E. coli, wheat germ, or rabbit reticulocyte lystate.  
These systems have proven invaluable in expressing toxic proteins.  T7 RNA 
polymerase-mediated cell-free transcription and translation of proteins from degenerate 
DNA libraries has enabled the in vitro evolution of binding species (Levy and Ellington, 
2008) DNA modifying enzymes (Tawfik and Griffiths, 1998; Doi et al., 2004), and other 
enzymes (Griffiths and Tawfik, 2003; Mastrobattista et al., 2005; Lu et al., 2014). 
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In vitro transcription 
 The relative simplicity of phage RNA polymerases makes them ideal for the 
generation of an abundance of RNA not only in vivo, but also in vitro.  Purified T7 or 
SP6 RNA polymerases were shown to transcribe RNA in vitro with digested plasmid 
containing their respective cognate promoters as the template (Melton and Krieg, 1984; 
Schenborn and Mierendorf, 1985).   Importantly, no additional proteins or cofactors were 
needed for prolific transcription.  The full power of in vitro transcription was then 
realized with the chemical synthesis of DNA oligonucleotides containing a T7 promoter 
followed by an arbitrary sequence.  This enabled the production of milligram quantities 
of any short RNA sequence.  The transcription of PCR products (Stoflet et al., 1988) or 
cDNA (Kwoh et al., 1989; Guatelli et al., 1990) only expanded the utility of T7 RNA 
polymerase-based in vitro transcription.  The use of degenerate DNA templates and in 
vitro transcription by T7 RNA polymerase has served as the foundation of the in vitro 
selection of aptamers (Tuerk and Gold, 1990; Ellington and Szostak, 1990), ribozyme 
ligases (Bartel and Szostak, 1993; Levy et al., 2005; Wochner et al., 2011), and other 
ribozymes (Wilson and Szostak, 1995; Agresti et al., 2005; Lau and Ferré-D’Amaré, 
2013).  
In vivo and in vitro transcriptional circuitry  
The high degree of activity, reliability, and specificity of T7 RNA polymerase has 
made it not only the core of directed evolution experiments, but also of increasingly 
complex transcriptional circuitry.  It has allowed robust and predictable gene expression 
for metabolic engineering and RNA production for nucleic acid computation.   
The Voigt Lab took advantage of the orthogonality and tight regulation of the T7 
RNA polymerase expression system to learn about the native regulation of a gene cluster.  
Specifically, they rebuilt the Klebsiella oxytoca nitrogen fixation gene cluster from the 
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bottom up such that each gene was driven from a T7 promoter (Temme et al., 2012b).  
This removed any known or as yet undiscovered gene regulation from cryptic binding 
sites and promoters, pause sites, small RNAs, or other regulatory mechanisms.  The 20 
genes were arranged into four operons, each with a different strength T7 promoter (as 
noted above, mutations in the -4 to +4 region of the promoter can reduce activity without 
ablating it).  Amazingly, the synthetic cluster retained about 8% of the activity of the 
native cluster. 
The Church Lab took advantage of the predictable, specific, and robust gene 
expression characteristics of T7 RNA polymerase in their metabolic engineering efforts.  
They used multiplex automated genome engineering (MAGE) to deliver T7 promoters 
upstream of up to 12 genes in the indigo biosynthetic pathway (Wang et al., 2012).   
Upon addition of a plasmid expressing T7 RNA polymerase, indigo production was 
increased two to three-fold over strains with no added promoters.  This approach allowed 
them to quickly optimize indigo production, and the semi-random insertion allowed them 
to uncover important epistatic and synergistic relationships in the metabolic pathway.  It 
should be noted that this process could be further optimized by introducing degeneracy 
into the T7 promoters, thus allowing the relative gene dosage to be tuned.   
The Winfree Lab has made extensive use of T7 RNA polymerase, using it as the 
core of in vitro transcriptional circuitry.  They have devised several systems based on the 
notion that a RNA transcript may inhibit or activate the formation of an active T7 
promoter.  For example, the RNA output from one transcriptional unit could inhibit a 
second unit, whose product could activate the first unit.  This results in oscillatory 
behavior (Kim and Winfree, 2011).  Similar approaches have yielded bistable switches 
(Kim et al., 2006), as well as inverter or repeater circuits (Subsoontorn et al., 2012).   
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PREVIOUS T7 RNA POLYMERASE ENGINEERING AND EVOLUTION EFFORTS 
The above demonstrations illustrate the power and versatility of T7 RNA 
polymerase, and, recognizing this, several groups have endeavored to evolve or engineer 
T7 RNA polymerase to enhance or alter its properties.   Below are some of the most 
prominent of such efforts. 
Promoter recognition 
T7 promoter evolution 
The directed evolution of the T7 RNA polymerase:promoter system started with a 
probing of the sequence space of the promoter.  E. coli cells were co-transformed with 
two plasmids.  The first plasmid contained T7 RNA polymerase and the second contained 
a mutagenized library of the T7 promoter controlling the expression of chloramphenicol 
acetyltransferase (Ikeda et al., 1992) (Figure 1-3).  Any bacteria growing on 
chloramphenicol plates, therefore, harbor T7 promoters that can be recognized by T7 
RNA polymerase.  This work uncovered several promoters of varying strengths and 
revealed the importance of some residues that could never vary.   
 
Figure 1-3.  Antibiotic based selection.   
T7 RNA polymerase (T7 RNAP) and its promoter (PT7) must function together in order 
to drive chloramphenicol acetyltransferase (CAT), allowing its host to survive in the 
presence of chloramphenicol. 
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Rational T7 RNA polymerase and T7 promoter mutation studies 
These efforts were followed by a suite of studies, in which defined mutations 
were made to the promoter, the polymerase, or both, and the strength of the resulting pair 
was assayed in vitro.  It was shown that the promoter specificity of T7 RNA polymerases 
could be changed with a single mutation.  While the closely related T3 and T7 RNA 
polymerases only weakly recognize one another’s promoters, single amino acid 
mutations can switch their respective preferences.  That is, an N748D mutation in T7 
RNA polymerase enables it to transcribe from the T3 promoter (Raskin et al., 1992).   
This was followed by an extensive analysis, in which T7 RNA polymerase and the 19 
possible mutants at the N748 position were tested for their ability to transcribe from the 
T7 promoter or one of the nine possible mutants that differ from the T7 promoter by a 
single base pair at either the -12, -11, or -10 position.  This analysis highlighted the  
importance of the contact between N748 and the -11 and -10 position, and generated 
several somewhat orthogonal polymerase:promoter pairs (Raskin et al., 1993).  Similar 
work was done with Q758 and the -8 position (Rong et al., 1998) and R756 with the -11, 
-10, and -9 positions (Imburgio et al., 2000).   
Expansion of T7 RNA polymerase promoter specificity with an autogene selection  
The Ellington Lab looked to evolve not only the promoter, but the RNA 
polymerase itself (Chelliserrykattil et al., 2001).  In this directed evolution platform the 
T7 promoter drives the expression of the T7 RNA polymerase gene itself, a so called 
autogene (Figure 1-4) (Dubendorff and Studier, 1991).  In the autogene circuit, an active 
polymerase:promoter pair would form a positive-feedback loop in which the 
concentration of T7 RNA polymerase mRNA and protein would increase exponentially.  
E. coli cells are transformed with a promoter or polymerase library, and, after a growth 
period, mRNA is collected and amplified by RT-PCR.  Since active autogenes create 
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thousands of copies of their mRNA, the recovered RT-PCR product is enriched for active 
autogenes.  Several cycles of cloning, electroporation, and RT-PCR yields a population 
of active autogenes.  A final screening step is then performed, in which autogene clones 
are replica-plated onto a fully-inducing media.  Some colonies are unable to grow on 
inducing plates, presumably because they are burdened by the metabolic load associated 
with a fully-induced, active autogene.  These colonies are picked from the original (non-
inducing) plate and sequenced. 
 
Figure 1-4.  Autogene based selection.   
T7 RNA polymerase (T7 RNAP) is driven by its own promoter (PT7), resulting in a 
positive feedback loop yielding high concentrations of mRNA.  Active variants were 
screened for their ability to inhibit host growth when fully induced.  A selection in which 
a library of T7 RNA polymerase mutants had to use a different promoter each round of 
selection yielded two generalist polymerases, each capable of using multiple promoters 
(Chelliserrykattil et al., 2001).   
In one such autogene selection, the critical -11 position was mutated from G to C 
(similar to the related T3 promoter), and the amino acid residues R746, L747, and N748 
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were randomized.  Sequencing from Round 3 showed a convergent population in which 
R746 and L747 reverted to wild type, while the N748D mutation fixed in the population.  
The T7 RNA polymerase N748D mutant had been previously shown to recognize T3-like 
promoters, thus illustrating the power of this method (Chelliserrykattil et al., 2001).    
This initial success was followed with a more ambitious selection, in which the 
polymerase and promoter were both randomized.  Specifically, -8 to -11 of the promoter 
was randomized, as were N748, R756, and Q758.  As above, active autogene mRNA was 
isolated and re-cloned.  Since mRNA does not contain the promoter sequence, a given 
polymerase was cloned under the control of a different promoter each round of selection.  
The dominant polymerase that emerged, Q758C, was a generalist.  It was found paired 
with GACT (wild type) promoter as well as GTTA, GTCA, GATA, GACG, and TGTA 
promoters.  Another variant, “R3-17” (N748A, R756M, Q758S) was paired with the 
GGTA promoter, but could also utilize GACT (wild type), TATA, and TGTA.  Clearly, 
this autogene selection is an effective strategy for the evolution of promoter specificity 
generalist mutants of T7 RNA polymerase (Chelliserrykattil et al., 2001).  
Selection for altered T7 RNA polymerase promoter recognition with PACE 
The Liu Lab has recently developed a novel platform for directed evolution, 
called phage-assisted continuous evolution (PACE) (Esvelt et al., 2011).  PACE ties a 
gene’s function to the propagation of bacteriophage M13 (Figure 1-5).  M13 is both 
deprived of its natural gene III, and also provided with a library of another gene.  This 
library must execute some function in order to drive the expression of gene III from a 
plasmid carried by the host.  The gene III product must be expressed in order to create 
infectious progeny phage particles.  Fresh media and hosts containing the gene III 
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plasmid are continually added and a fraction of culture and hosts are continually 
eliminated, thus M13 must propagate in order to remain in the population. 
The pilot experiment placed gene III on a plasmid under the control of a T7 
promoter variant, and the T7 RNA polymerase gene in the M13 genome.  Passage in this 
system enriched for M13 phages containing T7 RNA polymerase mutants capable of 
recognizing this synthetic promoter.  This system has produced T7 RNA polymerase 
mutants capable of recognizing a T3-like promoter (Esvelt et al., 2011), a more divergent 
promoter resembling a hybrid of the T3 and SP6 promoters (Dickinson et al., 2013), and 
more recently has been tuned to increase stringency (Carlson et al., 2014).   
 
 
Figure 1-5.  Phage-assisted continuous evolution.   
A library of M13 bacteriophage, lacking gene III (gIII), but possessing a T7 RNA 
polymerase (T7 RNAP) library infects E. coli host cells.   The phage-provided T7 RNA 
polymerase must recognize a synthetic T7 promoter variant (PT7) in order to produce the 
gene III product (red), which is needed to create infectious progeny (Esvelt et al., 2011). 
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Rational engineering of promoter specificity mutants by phylogenetic part mining 
The Voigt Lab took a part-mining approach to the problem of T7 RNA 
polymerase substrate specificity (Temme et al., 2012a).  The promoter specificity loops 
(amino acid residues 745 to 761) from three related bacteriophage-encoded RNA 
polymerases (T3, K1F, and N4) were grafted in place of the T7 RNA polymerase 
specificity loop.  The resulting chimeras were able to use promoters resembling the 
promoter used by those bacteriophage polymerases with about a 10-fold specificity over 
non-cognate promoters.   
Thermal stability 
The utility of T7 RNA polymerase in various in vitro transcription assays has 
driven interest in its ability to be used as part of an isothermal nucleic acid detection 
system based on cycles of transcription and reverse transcription (Kwoh et al., 1989; 
Guatelli et al., 1990; Compton, 1991).  This has, in turn, driven a need for a thermal-
stable RNA polymerase, so that these techniques can be performed at elevated 
temperatures, thus reducing mispriming and problematic secondary structure.  This 
problem was addressed using an antibiotic-based selection system similar to that depicted 
in Figure 1-3 where active T7 RNA polymerase variants are enriched based on their 
ability to confer chloramphenicol resistance to their host.  The distinctive elements were 
the nature of the host, Geobacillus stearothermophilus (formerly Bacillus 
stearothermophilus), and the plating conditions (45 °C to 50 °C) (Sugiyama et al., 2009).  
The resulting mutants were sequenced and the mutations S430P, S633P, F849I, and 
F880Y were found to predominate.  The reported oligonucleotide primers code for a fifth 
mutation N433T, but the mutation is not referenced in the text.  The mutant reported is 
active at 37 °C and 50 °C.   
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Promoter clearance  
Like other RNA polymerases, T7 RNA polymerase goes through cycles of 
abortive transcription before transitioning to the elongation phase.  This leads to a 
heterogeneous mixture of RNA products in an in vitro transcription reaction.  This can be 
especially problematic when a non-ideal initially transcribed sequence (ITS) is utilized.  
As noted above, initiation with purines (especially GTP) is quite favorable for de novo 
transcription.  Pyrimidine rich initiation can lead to low yields and excessive 
accumulation of short products.  To overcome this limitation, a directed evolution 
approach was taken (Guillerez et al., 2005).  A library of T7 RNA polymerase mutants 
(made by hydroxylamine mutagenesis) was transformed into an E. coli strain in which the 
T7 promoter (with a non-ideal ITS) drives the lacZ gene.  Plating on X-gal revealed 
clones of T7 RNA polymerase capable of initiating transcription with a poor ITS.  The 
P266L mutation, especially, mitigated the ill effects of a T-rich ITS, facilitating promoter 
clearance and a transition to elongation.     
Substrate specificity 
Nucleic acid with modified bases can be chemically synthesized, but it is often 
preferable to produce modified RNA by in vitro transcription, especially for in vitro 
selection (Knudsen et al., 2002). T7 RNA polymerase is an ideal enzyme for the 
production of large quantities of RNA in vitro, and has previously been engineered and 
evolved to have an expanded substrate range.   
Rational mutations conferring expanded substrate specificity in T7 RNA polymerase 
The Y639F mutation in T7 RNA polymerase was shown to result in a lower 
protein yield per transcript, suggesting a role in transcript homogeneity (Makarova, 1995) 
and the corresponding residue in structurally homologous DNA polymerase was known 
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to be important for fidelity (Carroll et al., 1991) and for binding dNTPs (Polesky et al., 
1990).  These insights led multiple groups to investigate the substrate specificity of the 
Y639F mutant.  Y639F (now available commercially as “durascribe”) allows for the in 
vitro transcription of RNA containing dNTPS as well as nucleotides with 2′-fluoro and 
2′-amino modified ribose (Kostyuk et al., 1995; Sousa and Padilla, 1995; Padilla and 
Sousa, 1999).  
The above relationship between Y639F and the 2′-OH group of the NTP substrate 
was confirmed by several crystal structures (Cheetham and Steitz, 1999; Tahirov et al., 
2002; Temiakov et al., 2004) (Figure 1-6).  The hydroxyl group of Y639 makes direct 
contact with the 2′-OH group of the incoming nucleotide, and is thus associated with the 
incorporation of unnatural substrates.  The structures also reveal that H784 makes contact 
with the 2′-OH group of the most recently added nucleotide.  H784A mutations were 
therefore investigated.  The Y639F, H784A (“FA”) double mutant can incorporate 
nucleotides with bulky modifications at the 2′ position (e.g. 2′-O-methyl) (Brieba and 
Sousa, 2000; Padilla and Sousa, 2002) presumably because the H784A mutation 
eliminates premature termination following the incorporation of a modified nucleotide. 
 16 
 
Figure 1-6. T7 RNA polymerase interaction with ribose moieties.    
The nascent RNA and incoming nucleotide (pink) shown inside the T7 RNA polymerase 
active site (green and blue).  DNA and some protein loops have been omitted for clarity.  
Y639 makes contact with the 2′-OH group of the incoming nucleotide and H784 makes 
contact with the 2′-OH group of the most recently added nucleotide.  R425, G542, Y639, 
and H784 (blue) have been the subject of directed evolution studies.   This figure is based 
on the crystal structure of T7 RNA polymerase in the elongation phase, PBD accession 
number 1SOV (Temiakov et al., 2004).   
Directed evolution of expanded substrate specificity in T7 RNA polymerase 
The Ellington Lab has previously taken a directed evolution approach, in which 
the aforementioned Y639 and H784 residues, as well as the important R425 and G542 
were randomized (Chelliserrykattil and Ellington, 2004).  The resulting library was 
subjected to an antibiotic-based selection similar to that described above (Figure 1-3) in 
which hosts harboring active polymerases could survive on chloramphenicol plates.  Thus 
the population was enriched for T7 RNA polymerase variants that retained the ability to 
transcribe RNA in vivo (with natural ribose).  This population was then screened for 
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altered substrate specificities in vitro.  A mutant, termed "RGVG," (R425, G542, Y639V, 
H784G plus additional E593G and V685A mutations that arose organically during the 
selection) showed strong activity with 2′-O-methyl UTP.  A second mutant, termed 
"VRS," (G542V and H784S as well as an additional H772R mutation) was able to 
incorporate 2′-fluoro modified pyrimidines.   
More recent works include a high throughput screen for derivatives of RGVG 
with enhanced 2′-O-methyl recognition.  This approach uncovered the “2P16” mutant, a 
mutant of RGVG with seven additional mutations (Siegmund et al., 2012).  A similar 
approach, with R425 randomized yielded the “R425C” mutant (Ibach et al., 2013).  Each 
of these mutants is reported to enable the incorporation of 2′-O-methylnucleotides. 
CONCLUSION 
The above biological insights into, laboratory uses of, and attempts to improve T7 
RNA polymerase have informed and shaped experiments that are the subject of the 
remainder of this dissertation.  Some of the limits of the directed evolution schemes 
previously described provided lessons into the nature of molecular evolution.  Some of 
the mutants created in the works described in this chapter are directly compared to the 
mutants described in the ensuing chapters.  The strengths and weaknesses of various 
approaches will be explored in an attempt to lay out the best strategies for future directed 
evolution undertakings.   
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Chapter 2:  T7 RNA polymerase evolution using an in vitro autogene 
system 
Biological life likely started with simple molecular replications, which, over time, 
elaborated function becoming increasingly complex multi-molecular consortia (Meyer et 
al., 2012).  The study of abiotic replication systems can therefore lend insight into the 
origins of life.  Among the simplest molecular replications are small nucleic acids that 
can catalyze their own formation from smaller parts (von Kiedrowski, 1986; Zielinski 
and Orgel, 1987; Lincoln and Joyce, 2009).  These systems are simple enough that they 
are resistant to passively replicating parasites, but more complicated systems that include 
enzymes in the replication process are not so lucky.  As was seen with the Qβ 
bacteriophage genome, continuous nucleic acid replication by an enzyme leads to the 
accumulation of shorter nucleic acids (Haruna and Spiegelman, 1965) because they can 
be replicated faster than their full-length competitors (Bull and Pease, 1995).  This 
problem can be mitigated by the introduction of compartments to confine enzymatic 
function (linking genotype to phenotype) and exclude parasites.  The abiotic self-
replication of the Qβ replicase (Urabe et al., 2010) and Taq DNA polymerase (Ghadessy 
et al., 2001) with in vitro compartmentalization has previously been shown.  In this 
chapter, the creation of an in vitro T7 RNA polymerase replicator, its properties, and its 
lessons for molecular replication and evolution are discussed.   
INTRODUCTION 
Background and rationale 
The directed evolution systems described in the previous chapter each possess 
their own strengths and limitations.  Selections in which T7 RNA polymerase mutants are 
tasked with the expression of chloramphenicol acetyltransferase (Ikeda et al., 1992; 
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Sugiyama et al., 2009; Chelliserrykattil and Ellington, 2004) are limited by a problem of 
thresholding.  That is, if a mutant is active enough to produce a minimal amount of 
chloramphenicol acetyltransferase it will survive the selection.  Any mutant that is more 
active gets no benefit from this added activity, and also faces a penalty because it puts a 
higher metabolic load on its host, lowering its growth rate.  Selections with this 
mechanism are therefore prone to generating RNA polymerases with moderate activity.   
The in vivo autogene system (Figure 1-4), in contrast, is not limited by 
thresholding (Dubendorff and Studier, 1991; Chelliserrykattil et al., 2001; Finn et al., 
2004).  A more active T7 RNA polymerase can, in theory, make more copies of its own 
mRNA across all levels of activity.  In practice however, the most active autogenes likely 
inhibited host growth enough to eliminate themselves from the population.  Thus, these 
selections also produced RNA polymerases of moderate activity.  Indeed, the Q758C 
mutant was found using the GACT (wild type) promoter far more often than the GACG 
promoter in this experiment, but Q758C will be shown to prefer the GACG promoter by 
at least 2.5 fold (Table 3-2).  Thus, the selection favored an inferior polymerase:promoter 
pair when a more active pair was possible.   
In order to eliminate the effects of thresholding and host growth, it was proposed 
to eliminate the hosts altogether.  This could be accomplished by replacing some of the 
functions of the host (i.e. translation machinery) with a cell-free translation lysate.  This 
would allow a large library of autogenes (in the form of degenerate PCR products) to be 
transcribed (kick-started by a different RNA polymerase) and then translated by the 
lysate machinery.  The characteristic positive feedback would then ensue, allowing 
functional autogenes to be exponentially amplified, without regard to the health of any 
host. 
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Bacterial hosts, while fragile, provide a directed evolution system with the critical 
element of compartmentalization.  Since each host cell usually receives only one copy of 
the gene under selection, it is physically isolated from all other competitors.  Thus, its 
genotype and phenotype are effectively linked.  The use of cell-free lysate as the basis of 
selection removes this inherent advantage to cell-based systems.  A new solution can be 
found in in vitro compartmentalization (IVC) by water-in-oil emulsion.  IVC has been 
shown to be effective in confining a gene product’s function (Tawfik and Griffiths, 1998) 
and in preventing shorter parasites from overrunning an entire population (Urabe et al., 
2010).  Thus a T7 autogene in cell-free lysate with in vitro compartmentalization should, 
in theory, be evolvable, and the most functional variants should thrive. 
Prior work toward implementation of the in vitro autogene 
The in vitro autogene was first implemented by Eric Davidson of the Ellington 
Lab.  His early efforts were based on the E. coli S30 Extract System for Linear 
Templates.  This lysate contained the E. coli RNA polymerase, which was used to kick-
start the auto-feedback system by initially transcribing T7 RNA polymerase from a tetA 
promoter.  The positive feedback transcription would proceed from a T7 promoter 
located upstream of the tetA promoter, thus “feedback transcript” mRNA would contain a 
unique sequence not found in the “initial transcript” mRNA.  While protein production 
could be monitored in this system, mRNA (from either promoter) could not be detected.  
It was determined after many trials that a eukaryotic system (rabbit reticulocyte lysate; 
RRL) initiated by the SP6 RNA polymerase was the most suitable implementation of the 
in vitro autogene (Davidson et al., 2012) (Figure 2-1).   
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Figure 2-1.  In vitro autogene. 
SP6 RNA polymerase (red) drives initial transcription from its cognate promoter (PSP6; 
red arrow), producing “initial transcript” (red line).  This is translated into T7 RNA 
polymerase (green), which then transcribes “feedback transcript” (green line) from the T7 
promoter (PT7; green arrow). 
While feedback transcripts could be detected from the transcription and 
translation (TNT) reaction in bulk solution, the in vitro autogene needed to be able to 
function in emulsion in order to allow evolution to occur.  Several factors were optimized 
in order to improve the function of the system.  An oil and surfactant mixture of 96% 
mineral oil (Sigma) and 4% Abil EM90 (Evonik) had previously been shown to be 
compatible with RRL (Ghadessy and Holliger, 2004), and was found to be suitable for 
this system.  The inclusion of 5′ biotin groups stabilized the DNA template and increased 
mRNA yield. An F880Y mutation, previously shown to aid in thermal stability 
(Sugiyama et al., 2009), was added to the T7 RNA polymerase open reading frame.  
Finally, the inclusion of an EMCV IRES facilitated translation in the eukaryotic system.  
With the improved formulation, feedback transcripts accounted for 40% of mRNA 
recovered.   
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Before attempting a selection with a complex library, a two-member library 
“mock” selection was performed by Eric Davidson.  Initially, 10% of the population was 
active autogene (WT) and 90% was inactive autogene (containing premature stop codons; 
XX).  After TNT in emulsion, recovery of mRNA, and RT-PCR, eight of 10 clones 
sequenced were WT, suggesting at least moderate enrichment of active sequences.  
However, these efforts were not built upon because multiple rounds of selection could not 
be performed.  An initial “library” comprising only WT templates could go through one 
round of emulsion TNT, recovery, and RT-PCR, but the reamplification of the second 
such round produced a smeared product.  Sequencing of this population showed at least 
two mutations per kilobase as well as large deletions (Davidson et al., 2012).  No RT-
PCR band could be seen from Round 3 reamplification.  At this point, the author and 
Jared Ellefson of the Ellington Lab began work on the implementation of the in vitro 
autogene as a platform for directed evolution.   
RESULTS AND DISCUSSION 
In vitro autogene optimization 
Rounds of selection of the in vitro autogene are depicted in Figure 2-2.  
Essentially, purified autogene template DNA is added to rabbit reticulocyte lysate (RRL) 
on ice (to prevent premature reactions), and the mixture is emulsified such that each 
compartment is expected to contain zero or one DNA template. SP6 RNA polymerase 
initiates transcription, and the initial transcript is translated by RRL machinery.  The 
newly translated T7 RNA polymerase then transcribes from the T7 promoter.  After an 
incubation period, the emulsion is broken with chloroform, mRNA is recovered, and 
template DNA is digested.  Transcription from the T7 promoter is specifically amplified 
 30 
by RT-PCR.  Additional PCR steps use primers that reintroduce the T7 promoter and 5′ 
biotin groups.  The template DNA is then prepared for further rounds of selection. 
 
Figure 2-2.  In vitro autogene based selection.   
The autogene template DNA is emulsified in rabbit reticulocyte lysate, wherein a 
transcription and translation (TNT) reaction occurs.  After an incubation period, mRNA 
is recovered, and feedback transcripts are specifically amplified by RT-PCR.  Subsequent 
PCR steps reintroduce the T7 promoter (PT7) and 5′ biotin groups, preparing the DNA for 
further rounds of selection. 
The above schema, however, cannot be propagated past a second round even 
when the initial library input is 100% active autogenes (WT), and by the second round, 
products are truncated and heavily mutated.  Figure 2-3 shows typical RT-PCR products 
from a first or second round of selection.  The two groupings on the left show failed cycle 
course RT-PCRs of two independent Round 2 mRNAs.  The middle grouping is a 
negative control in which the input DNA was all non-function autogenes with two 
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premature stop codons (XX).  The two groupings on the right show successful cycle 
course RT-PCRs of two independent Round 1 mRNAs.   
 
Figure 2-3.  Failed propagation of the in vitro autogene selection.   
For WT A-D, the initial library input DNA is 100% active autogenes.  For XX, the initial 
library input DNA is 100% non-function autogenes with two premature stop codons 
(XX).  A and B are similar, C and D are similar.  A and B show the cycle course RT-PCR 
of the mRNA recovered from a second round of selection, which is smeared.  C and D 
show the cycle-course RT-PCR of the mRNA recovered from a first round of selection, 
which amplifies at the correct size (arrow).  XX does not show a band, as expected.     
One of the major problems seen in the prior attempts at turning serial rounds of 
selection with the WT autogene was a high error rate (about one mutation per kilobase 
per round).  This is partially due to the error associated with transcription by T7 RNA 
polymerase, which has an error rate of about 6 x 10-5 in cells (this may be higher in 
emulsion) (Brakmann and Grzeszik, 2001), and reverse transcription by SuperScript III, 
which has an error rate of about 3 x 10-5 (Goldsmith and Tawfik, 2009).  A larger 
contributor was likely the error rate of Platinum Taq DNA polymerase High Fidelity (a 
mixture of hot start Taq DNA polymerase and Deep Vent DNA polymerase), which was 
used in all PCR steps.  Platinum Taq DNA polymerase High Fidelity is used for “tricky” 
amplification and has been seen to work when other DNA polymerases do not.  Thus, 
there was concern that a move away from Platinum Taq DNA polymerase High Fidelity 
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would hamper efforts to amplify cDNA from the emulsion (which is at a low 
concentration and possibly co-purified with inhibitors).   As a test, autogene cDNA was 
amplified by Accuprime Pfx DNA polymerase (KOD DNA polymerase), Pfx50 DNA 
polymerase (from Thermococcus zilligii), Phusion DNA polymerase (a modified Pfu 
DNA polymerase), and PfuUltra II Hotstart (a modified Pfu DNA polymerase) as well as 
Platinum Taq DNA polymerase High Fidelity.  Only Platinum Taq DNA polymerase 
High Fidelity and PfuUltra II Hotstart could effectively amplify the cDNA (Figure 2-4).  
The fidelity of PfuUltra II Hotstart was assayed by PCR amplifying a plasmid of known 
sequence and sequencing the resulting amplicon.  After 50 cycles of PCR (the number 
commonly faced between rounds), no errors were found in several kilobases of sequence.  
It should be noted that PfuUltra II Hotstart is often used for general cloning and is 
considered to have one of the lowest error rates among commercially available DNA 
polymerases.  PfuUltra II Hotstart was therefore used in all subsequent autogene 
selections. 
 
Figure 2-4.  DNA polymerase comparison for PCR amplification of autogene cDNA.    
Accuprime Pfx DNA polymerase (KOD), Pfx50 DNA polymerase (Pfx50), Platinum Taq 
DNA polymerase High Fidelity (Taq Hifi), Phusion DNA polymerase (Phusion), and 
PfuUltra II Hotstart DNA polymerase (Pfu) were used to PCR amplify autogene cDNA.  
A variable number of cycles were performed. 
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 The other major problem in the previous instantiation of the autogene selection 
was the accumulation of large deletions, which presumably arise during reverse 
transcription.  One possible explanation is excessive secondary structure in the EMCV 
IRES and the T7 RNA polymerase coding sequence.  To address the issue of structure in 
the IRES, the “IRESite” database was searched for suitable alternatives (Mokrejs et al., 
2010).  The database contained 10 IRESes that had been experimentally validated in 
rabbit reticulocyte lysate (RRL).  Three of these were eliminated from consideration due 
to their lengths in excess of 900 nucleotides.  An additional two IRESes were considered 
after a literature search suggested their compatibility with RRL (Kang et al., 2009; 
Vallejos et al., 2010).  The nine IRES sequences under consideration were inputted into 
NUPAC folding software, and analyzed for secondary structure at several temperatures.  
All IRESes have considerable secondary structure at 30 °C, the temperature at which they 
function.  Three IRESes (SWSS, crTMV, and Gypsy) were markedly less structured than 
the EMCV IRES at 55 °C, the temperature at which they serve as the template for reverse 
transcription (Figure 2-5).  Each of these IRESes were built from oligodeoxynucleotides 
using thermodynamically balanced inside-out PCR (Gao, 2003).  These IRESes and a 
random “N50” sequence were each assembled into autogene constructs and tested for 
translation in RRL using [35S]-methionine for detection by autoradiography.  SWSS 
appeared to be non-functional and was removed from consideration.  EMCV, N50, 
Gypsy, and crTMV were then tested for their compatibility with reverse transcription.  
mRNA was transcribed, purified, and reverse transcribed using [α32P]dATP for detection 
by autoradiography (Figure 2-5).  crTMV was not well reverse-transcribed.  Full length 
product from EMCV-mRNA could be seen, but shorter products were apparent.  Gypsy-
mRNA was slightly better and N50 was by far the best.  Using an N50 pool as an IRES 
could be problematic (enhancing or reducing translation and forming cryptic promoters 
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or primer binding sites).  However, reports have suggested that unstructured regions are 
all that is needed for translation initiation in lysate (Mureev et al., 2009), and the exact 
N50 sequences were unlikely to affect translation.  Cryptic promoters and primer binding 
sites would be disfavored and lost from the population.  It was therefore judged that these 
considerations were outweighed by the improved reverse transcription.  The N50 leader 
sequence was used in all subsequent autogene selections performed by Jared Ellefson, 
and the Gypsy IRES was used in selections performed by the author.   
 
Figure 2-5.  Replacement of the EMCV IRES.    
Left) The NUPACK generated secondary structure of the least structured IRESes 
considered, as well as the EMCV IRES.  The predicted folding of RNA at 55 °C is 
shown.  Right)  Reverse transcription of IRES-T7 RNA polymerase mRNA.  The N50 
“IRES” gave the most robust signal, followed by the Gypsy IRES.   
 35 
Aside from IRESes, the natural T7 RNA polymerase coding sequence is heavily 
structured.  Some of the truncation likely came from improper reverse transcription of the 
open reading frame itself.  To address this, Ben Braun of the Ellington Lab devised an 
algorithm to make iterative “mutations” to the mRNA and “evolve” toward a sequence of 
minimal secondary structure.  The resulting sequence of T7 RNA polymerase with 
reduced secondary structure (T7 RSS) contains fewer and shorter stems and was expected 
to be less problematic than the wild type sequence (Figure 2-6).  The T7 RSS gene was 
cloned, PCR amplified to create the linear autogene, and used in all subsequent 
selections.   
 
Figure 2-6.  Recoding the T7 RNA polymerase open reading frame.    
The NUPACK generated secondary structure of the wild type T7 RNA polymerase (WT 
T7 RNAP) coding sequence and that of the T7 RNA polymerase with reduced secondary 
structure (T7 RSS).  The predicted folding of RNA at 55 °C is shown. 
In vitro autogene selection 
Having implemented the described changes, both Jared Ellefson and the author 
were able to routinely turn two to three rounds before smearing occurred.  Jared Ellefson 
was able to turn four successful rounds (with a smear on the fifth round).  Several clones 
from each round of this selection were sequenced, assayed, and analyzed by the author.   
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Eight to 10 variants from each round of selection were cloned and sequenced 
(Table 2-1).  Analysis of the sequencing data from each round of selection revealed that 
that while the number of point mutations increased with each round (about 2.5 per gene 
per round), the number of catastrophic mutations (nonsense and frameshift) did not 
increase and the proportion of synonymous mutations increased each round.   
 
Table 2-1.  Mutational analysis from an in vitro autogene selection.  
Although the Round 4 population was heavily mutated (averaging about 11 
mutations per gene), many of the mutations mapped to the peripheral loops of the fingers 
domain and the less catalytically relevant N-terminal domain (Figure 2-7).  There were 
few mutations in the promoter contact region (residues 85 to 106, 742 to 761, and 230 to 
243) or active site (residues 420 to 442, 536 to 543, 631 to 641, 778 to 788, and 808 to 
814) (Table 2-2).   
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Figure 2-7.  Location of mutations found in Round 4 of an in vitro autogene 
selection.  
T7 RNA polymerase (pale green), DNA including the T7 promoter (blue), and incoming 
nucleotides (yellow) are shown along with mutations found in any of the eight clones 
from Round 4 of the in vitro autogene selection (red).   
 
Table 2-2.  Sequence of clones from Round 4 of an in vitro autogene selection.  
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A functional assay showed that six out of eight clones from Round 4 were active, 
despite being highly mutated (Figure 2-8).  All of this suggests that “purifying selection” 
(Bershtein et al., 2008) was occurring, preferentially purging the deleterious mutations at 
the expense of neutral mutations.  However, the eventual collapse of the system suggests 
the low activity and high mutation rate of the system could not avoid mutating itself to 
death.   
 
Figure 2-8.  Function assay of eight clones from Round 4 of an in vitro autogene 
selection. 
T7 RNA polymerase variants were expressed in RRL, along with a PT7-GFP construct.  
PAGE and autoradiography (with [35S]-methionine) shows that six of the variants could 
produce GFP.  Wild type T7 RNA polymerase (WT) and negative control with premature 
stop codons (XX) are shown for comparison.  The WT value is defined as 100.  Numbers 
shown are the average and standard error from three independent measurements.  
CONCLUSION  
The limitations of the autogene can be understood as an example of “lethal mutagenesis” 
(Bull et al., 2007).  Essentially, a nucleic acid replicator must replicate itself faster than it 
mutates itself in order to survive.  More formally, to avoid extinction the following must 
be true: 
ƒ (e-Ud) > 1 or eUd < ƒ 
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Where ƒ is the fecundity of a replicator (the number of progeny per replicative cycle) and 
Ud is the average number of deleterious mutations that arise during a replicative cycle.  
In the context of the in vitro autogene selection, analysis of the sequences recovered from 
Round 1 indicated that there are about 1.5 non-synonymous mutations per gene.  Other 
models of protein mutation from the literature suggest that about 37% of mutations are 
deleterious (Bershtein et al., 2006, 2008; Soskine and Tawfik, 2010).  Ud can then be 
assumed to be about 37% of 1.5, or about 0.56.  The fact that extinction occurred 
suggests that fecundity must have been less than about 1.7.   
Since the same number of input DNA molecules goes into each round, the overall 
fecundity of the population is 1.0.  The firm constraint on the population size therefore 
means that the fecundity of a replicator is not merely an intrinsic property, but exists in 
the context of the library.  That is, a fecundity of 1.7 does not mean that the active 
replicator makes 1.7 transcripts, but that it makes enough transcripts to increase its 
proportion of the population by 1.7-fold.   
Interestingly, the lethal mutagenesis model with a constrained population size 
begins to resemble the “error catastrophe” (Eigen, 1971; Eigen and Schuster, 1977).  
Error catastrophe argues that a wild type replicator must have enough of a selective 
advantage over mutants to compensate for its error rate (i.e. the rate at which it creates 
mutants).  Specifically, to avoid error catastrophe: 
eε < σ 
where σ is the selective advantage of a given sequence over its mutant and ε is the error 
rate per base pair multiplied by the number of base pairs (similar to Ud, above).  As 
above, at least a 1.7 fold selective advantage is required to avoid catastrophe.   
 The limits of the autogene as a platform for directed evolution can be summed up 
as two problems: 1) the error rate is too high and 2) the selective advantage of the best 
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species is too low.  In the next chapter, a new selection scheme is introduced that 
addresses both of these problems.   
MATERIALS AND METHODS 
Template preparation 
Plasmids were generated in which the SP6 promoter was placed upstream of 
either wild type T7 RNA polymerase or a truncated version with two premature stop 
codons.  The T7 promoter was not included in the plasmid, due to toxic effects on the 
host.  PCR was then carried out with primers designed to extend the template to include 
the T7 promoter, a T7 terminator, and 5′ biotin groups.  PCR was carried out with either 
Platinum Taq DNA polymerase High Fidelity (Life Technologies) or PfuUltra II Hotstart 
(Agilent).  Intermediate PCR products were gel purified using Wizard Gel and PCR 
Clean-Up System (Promega).  The final PCR product was further purified by 
phenol:chloroform extraction.  In short, 100 μl of PCR reaction was mixed with 100 μl 
25:24:1 phenol:chloroform:isoamylalcohol pH 7.9 (Ambion).  After centrifugation, the 
(upper) aqueous phase was removed and mixed with 100 μl chloroform.  After 
centrifugation, the (upper) aqueous phase was removed and mixed with 10 μl 3 M sodium 
acetate, and 300 μl 100% ethanol.  The solution was stored at -20 °C for 30 minutes, and 
then centrifuged at 13,000 g at 4 °C for 30 minutes.  The supernatant was removed and 
the pellet was washed with 70% ethanol before being air-dried and resuspended in 50 μl 
water.  This yield of PCR product was quantified on an agarose gel using DNA 
quantitation standards. 
In vitro transcription and translation reactions in emulsion 
Selections were performed in TNT SP6 Quick Coupled Transcritpion Translation 
System (Promega) referred to as “RRL” hereafter.  Reactions contained 3 ng – 30 ng (109 
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- 1010 molecules) of full-length autogene template in 50 μl RRL.  Reactions were 
assembled on ice until emulsification. 
Individual tubes (Sarstedt, 95 x 16.8 mm polypropylene) were set up that 
contained 96 μl mineral oil and 4 μl Abil EM90 (Evonik) and placed on ice.  A stir bar 
(Spinplus 9.5 x 9.5 mm Teflon) was added to the tube containing the oil:surfactant 
mixture.  The tube was moved into a beaker containing ice water on top of a magnetic stir 
plate (Corning) and stirred on the “high” setting (1150 rpm) for one minute.  While 
stirring the oil:surfactant mixture, the 50 μl in vitro transcription and translation reaction 
was added drop-by-drop over one minute and then stirred for four additional minutes.  
The fully emulsified reaction was incubated at 30 °C for an additional two hours. 
The emulsion reaction was stopped by placing the tube on ice for 10 minutes and 
adding Stop Solution (50 mM Tris, pH 7.0, 50 mM EDTA) sufficient to bring the 
aqueous volume to 100 μl total.  The emulsion was broken by vortexing the reaction with 
one volume chloroform.  The reaction was centrifuged at 13,000 g to separate the 
aqueous phase from the organic phase.  The aqueous phase was removed for further 
purification. 
The aqueous phase (after breaking an emulsion reaction as above) was added to 
400 μl of Trizol reagent (Life Technologies).  The tube was shaken and incubated for two 
minutes at room temperature.  150 μl of chloroform was added, the tube was again 
shaken and incubated for two minutes to allow the phases to separate.  The reaction was 
centrifuged at 13,000 g at room temperature for two minutes.  The aqueous phase was 
removed and precipitated by addition of 1 μg of glycogen and 0.7 volumes of 
isopropanol.  After incubation at room temperature for 15 minutes the reaction was again 
centrifuged at 4 °C for 30 minutes.  The supernatant was removed and the pellet was 
washed with 70% ethanol before being air-dried.  
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The pellet was resuspended in 43 μl water and 0.1 volume 10x DNase buffer, and 
then 2 Units Turbo DNase (Ambion) and 40 Units RNasin Plus RNase inhibitor 
(Promega) were added, bringing the final volume to 50 μl.  The DNA digestion reaction 
was incubated at 37 °C for 30 minutes, and then 0.1 volumes DNase Inactivation Reagent 
was added.  The solution was mixed gently for two minutes and the DNase Inactivation 
Reagent was removed by centrifugation at 13,000 g for two minutes at 4 °C.  The 
aqueous supernatant was removed and could be stored at -80 °C or carried into further 
amplification reactions.  
Template regeneration 
Reverse transcription and PCR amplification of full-length mRNAs were 
performed in a single-step reaction using SuperScript III One-Step RT-PCR System with 
Platinum Taq High Fidelity (Life Technologies).  The RT-PCR product was gel purified 
and used for regeneration of the autogene template. This protocol is the same as 
described above. Briefly, there were two regenerative PCR steps.  The first PCR product 
was gel-purified and the second product was phenol:chloroform-extracted and ethanol-
precipitated.  The PCR steps add back the T7 promoter, 3′ UTR, and 5′ biotin groups.   
Cloning and sequencing 
Gel-purified RT-PCR products were amplified using primers that added 
appropriate restriction sites for cloning into a pASK sequencing vector.  Eight to 10 
clones from each round were sequenced using multiple primers that spanned the full 
length of the gene.  Sequences were assembled and analyzed using Geneious 
(Biomatters).  
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T7 RNA polymerase activity assay 
 A SP6 promoter and EMCV IRES were appended to the genes for T7 RNA 
polymerase variants isolated from Round 4 via overlap PCR.  DNA templates were gel-
purified, and 3 x 109 templates were mixed with RRL, 200 pM [35S]-methionine (1175 Ci 
/mmol; Perkins Elmer), and a plasmid containing the T7 promoter, EMCV IRES, and 
GFP gene.  The reaction mixtures were incubated at 30 °C for two hours, followed by 
addition of Stop Solution, 10 mM DTT, and 4x LDS loading dye (Life Technologies).  
Samples were analyzed on a 4-12% NuPAGE gel (Life Technologies) with 1x MOPS, 
transferred to a 0.45 μm nitrocellulose membrane (Life Technologies), and exposed to a 
storage phosphor screen (Molecular Dynamics) before imaging on a STORM 840 
Phospoimager (GE Healthcare).   Autoradiographs were analyzed using ImageQuant (GE 
Healthcare).  A band at 100 kDa indicated proper expression of the T7 RNA polymerase 
variants while a band at 27 kDa indicated expression of GFP, and thus T7 RNA 
polymerase activity. 
Reverse transcription assay 
To determine the suitability of IRES constructs, various autogene constructs were subject 
to in vitro transcription reactions using AmpliScribe-T7 High Yield Transcription Kit 
(Epicentre) under standard conditions.  RNA was purified as above (trizol/chloform 
extraction, isopropanol precipitation, and turbo DNAse.)  5 μl RNA was reverse 
transcribed with SuperScript III reverse transcriptase (Life Technologies) under standard 
20 μl reaction conditions.   Reactions included 2 μl [α32P]dATP (3000 Ci/mmol; 10 
mCi/ml).  Products were run on denaturing PAGE and gels were exposed to a storage 
phosphor screen (Molecular Dynamics) before visualization on a STORM 840 
Phospoimager (GE Healthcare).   Autoradiographs were analyzed using ImageQuant (GE 
Healthcare). 
 44 
REFERENCES 
Bershtein, S., Goldin, K., and Tawfik, D. S. 2008. Intense neutral drifts yield robust and 
evolvable consensus proteins. Journal of Molecular Biology 379:1029–44. 
Bershtein, S., Segal, M., Bekerman, R., Tokuriki, N., and Tawfik, D. S. 2006. 
Robustness-epistasis link shapes the fitness landscape of a randomly drifting protein. 
Nature 444:929–32. 
Brakmann, S., and Grzeszik, S. 2001. An error-prone T7 RNA polymerase mutant 
generated by directed evolution. Chembiochem 2:212–9. 
Bull, J. J., and Pease, C. M. 1995. Why Is the Polymerase Chain Reaction Resistant to In 
Vitro Evolution? Journal of Molecular Evolution:1160–1164. 
Bull, J. J., Sanjuán, R., and Wilke, C. O. 2007. Theory of Lethal Mutagenesis for Viruses. 
Journal of Virology 81:2930–2939. 
Chelliserrykattil, J., Cai, G., and Ellington, A. D. 2001. A combined in vitro/in vivo 
selection for polymerases with novel promoter specificities. BMC Biotechnology 
1:13. 
Chelliserrykattil, J., and Ellington, A. D. 2004. Evolution of a T7 RNA polymerase 
variant that transcribes 2’-O-methyl RNA. Nature Biotechnology 22:1155–60. 
Davidson, E. A., Meyer, A. J., Ellefson, J. W., Levy, M., and Ellington, A. D. 2012. An 
in vitro Autogene. ACS Synthetic Biology 1:190–196. 
Dubendorff, J. W., and Studier, F. W. 1991. Creation of a T7 autogene. Cloning and 
expression of the gene for bacteriophage T7 RNA polymerase under control of its 
cognate promoter. Journal of Molecular Biology 219:61–8. 
Eigen, M. 1971. Selforganization of matter and the evolution of biological 
macromolecules. Naturwissenschaften 58:465–523. 
Eigen, M., and Schuster, P. 1977. The Hypercycle. Naturwissenschaften 64:541–565. 
Finn, J., Lee, A. C. H., MacLachlan, I., and Cullis, P. 2004. An enhanced autogene-based 
dual-promoter cytoplasmic expression system yields increased gene expression. 
Gene Therapy 11:276–83. 
 45 
Gao, X. 2003. Thermodynamically balanced inside-out (TBIO) PCR-based gene 
synthesis: a novel method of primer design for high-fidelity assembly of longer gene 
sequences. Nucleic Acids Research 31:143e–143. 
Ghadessy, F. J., and Holliger, P. 2004. A novel emulsion mixture for in vitro 
compartmentalization of transcription and translation in the rabbit reticulocyte 
system. Protein Engineering, Design & Selection 17:201–4. 
Ghadessy, F. J., Ong, J. L., and Holliger, P. 2001. Directed evolution of polymerase 
function by compartmentalized self-replication. Proceedings of the National 
Academy of Sciences of the United States of America 98:4552–4557. 
Goldsmith, M., and Tawfik, D. S. 2009. Potential role of phenotypic mutations in the 
evolution of protein expression and stability. Proceedings of the National Academy 
of Sciences of the United States of America 106:6197–202. 
Haruna, I., and Spiegelman, S. 1965. Autocatalytic Synthesis of a Viral RNA in vitro. 
Science 150:884–886. 
Ikeda, R. A., Ligman, C. M., and Warshamana, S. 1992. T7 promoter contacts essential 
for promoter activity in vivo. Nucleic Acids Research 20:2517–24. 
Kang, S. T., Leu, J. H., Wang, H. C., Chen, L. L., Kou, G. H., and Lo, C. F. 2009. 
Polycistronic mRNAs and internal ribosome entry site elements (IRES) are widely 
used by white spot syndrome virus (WSSV) structural protein genes. Virology 
387:353–63. 
Von Kiedrowski, G. 1986. A Self-Replicating Hexadeoxynucleotide. Angewandte 
Chemie International Edition in English 25:932–935. 
Lincoln, T. A., and Joyce, G. F. 2009. Self-sustained replication of an RNA enzyme. 
Science 323:1229–1232. 
Meyer, A. J., Ellefson, J. W., and Ellington, A. D. 2012. Abiotic Self-Replication. 
Accounts of Chemical Research 45:2097–2105. 
Mokrejs, M., Masek, T., Vopálensky, V., Hlubucek, P., Delbos, P., and Pospísek, M. 
2010. IRESite--a tool for the examination of viral and cellular internal ribosome 
entry sites. Nucleic Acids Research 38:D131–6. 
Mureev, S., Kovtun, O., Nguyen, U. T. T., and Alexandrov, K. 2009. Species-
independent translational leaders facilitate cell-free expression. Nature 
Biotechnology 27:747–52. 
 46 
Soskine, M., and Tawfik, D. S. 2010. Mutational effects and the evolution of new protein 
functions. Nature Reviews. Genetics 11:572–82. 
Sugiyama, A., Nishiya, Y., and Kawakami, B. 2009. RNA Polymerase Mutants with 
Increased Thermostability. U. S. Patent. US 7,507,567 B2. 
Tawfik, D. S., and Griffiths, A. D. 1998. Man-made cell-like compartments for molecular 
evolution. Nature Biotechnology 16:652–656. 
Urabe, H., Ichihashi, N., Matsuura, T., Hosoda, K., Kazuta, Y., Kita, H., and Yomo, T. 
2010. Compartmentalization in a water-in-oil emulsion repressed the spontaneous 
amplification of RNA by Q beta replicase. Biochemistry 49:1809–1813. 
Vallejos, M., Ramdohr, P., Valiente-Echeverría, F., Tapia, K., Rodriguez, F. E., Lowy, 
F., Huidobro-Toro, J. P., Dangerfield, J. A., and López-Lastra, M. 2010. The 5’-
untranslated region of the mouse mammary tumor virus mRNA exhibits cap-
independent translation initiation. Nucleic Acids Research 38:618–32. 
Zielinski, W. S., and Orgel, L. E. 1987. Autocatalytic synthesis of a tetranucleotide 
analogue. Nature 327:346–347. 
 
  
 47 
Chapter 3:  Directed evolution of a panel of orthogonal T7 RNA 
polymerase:promoter pairs using compartmentalized partnered 
replication 
The engineering and evolution of T7 RNA polymerase with altered promoter 
specificity has been a goal of protein engineers and synthetic biologists for decades. 
Rational engineering and directed evolution approaches have been utilized, but in all 
cases the resulting T7 RNA polymerases transcribe from their cognate promoters weakly 
or indiscriminately transcribe from multiple promoters.  If T7 RNA polymerase mutants 
are to be useful in the development of complex transcriptional circuitry they will have to 
be both active and specific.  This chapter details a novel approach to the directed 
evolution of promoter recognition by T7 RNA polymerase.  This directed evolution 
platform, termed compartmentalized partnered replication (CPR), ties the in vivo 
recognition of a synthetic promoter by a T7 RNA polymerase mutant to the in vitro 
amplification of that mutant.  The product of these efforts is a panel of six T7 RNA 
polymerase:promoter pairs that are both active and orthogonal to one another.   
INTRODUCTION 
Background and rationale  
The need for orthogonal T7 RNA polymerase:promoter pairs  
The desire to create alternate versions of T7 RNA polymerase stems from its 
inherent utility in a range of applications.  T7 RNA polymerase’s robust activity in 
prokaryotic, eukaryotic, and in vitro systems and its orthogonality to all host machinery 
have made it uniquely qualified to serve as the core of synthetic transcriptional circuits, 
both in vivo and in vitro.  Examples of such circuits include the control of the nitrogen 
fixation cluster (Temme et al., 2012b) and pigment production in vivo (Wang et al., 2012; 
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Temme et al., 2012a) and nucleic acid computation in vitro (Kim et al., 2006; Kim and 
Winfree, 2011; Franco et al., 2011; Subsoontorn et al., 2012). As synthetic biological 
circuits become increasingly complex, it is desirable to precisely control modular 
synthetic transcriptional networks that function independently.  This can be achieved by 
engineering a repertoire of T7 RNA polymerase variants that each specifically recognizes 
a synthetic promoter.  Each orthogonal polymerase:promoter pair then acts as a 
transcriptional controller, analogous to bacterial sigma factors.  Similarly to sigma 
factors, they enable the precise and flexible temporal, spatial, or signal dependent control 
of RNA expression.   
The limits of previous approaches 
Previous attempts to alter the molecular recognition of T7 RNA polymerase have 
been overviewed in Chapter 1.  Single amino acid mutations that facilitate the 
recognition of mutant promoters have been found by screening (Raskin et al., 1993; Rong 
et al., 1998; Imburgio et al., 2000).  These mutant promoters were only one base pair 
removed from the wild type T7 promoter; thus they were not divergent enough to prevent 
recognition of multiple promoters by a given polymerase.   
Phylogenic part mining has been used to graft the specificity loop of related 
bacteriophage encoded RNA polymerase on the T7 RNA polymerase scaffold to allow it 
recognize chimeric promoters (Temme et al., 2012a).   These promoters are sufficiently 
divergent to allow for the specific recognition of a single promoter.  However, the grafted 
specifically loops were likely not optimally positioned in relation to the promoter, and 
thus the overall activity the polymerases were weak.     
A large change in the polymerase is likely required in order to recognize a 
promoter divergent enough from the wild type promoter to allow for orthogonality.  
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However, such a large scale change in protein architecture cannot (currently) be made 
using phylogenic and structural considerations alone.  Directed evolution is therefore 
uniquely able to achieve a change in promoter specificity sufficient to allow the specific 
recognition of a synthetic promoter.   
Existing methods for directed evolution of T7 RNA polymerase tend to link the 
transcriptional output of a mutant to the fitness of its host.  For example a T7 RNA 
polymerase mutant could drive expression of chloramphenicol acetyltransferase from a 
synthetic promoter and confer chloramphenicol resistance to its host (Ikeda et al., 1992).  
The T7 RNA polymerase would then be passively replicated based on its host’s fitness.  
Similarly, phage assisted continuous evolution (PACE) ties expression of M13’s gene III 
to the fitness of an M13 bacteriophage carrying a T7 RNA polymerase mutant (Esvelt et 
al., 2011; Dickinson et al., 2013).  In each case, the evolutionary success of the T7 RNA 
polymerase gene is dependent not on its actual transcriptional output, but on the fitness of 
its host.   
Tying directed evolution to host fitness is problematic for two reasons.  First, 
there is usually a threshold of gene output required to confer maximum advantage to the 
host (i.e. a given number of chloramphenicol acetyltransferase proteins are required to 
allow for growth on a given concentration of chloramphenicol).  Second, highly active 
polymerases that lead to the overexpression of a protein impart a costly metabolic load on 
their host.  T7 RNA polymerase mutants may find an optimal strategy of mediocrity.  
Mediocre polymerases can produce just enough protein to survive the selection, while 
imposing minimal metabolic load.  Thus, tying evolutionary success of a T7 RNA 
polymerase gene to the fitness of its host results in the evolution of polymerases of 
moderate activity.  This makes intuitive sense, as organisms must strike a balance 
between activity and resource allocation.   
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Moderately active polymerases are a problem because they have relatively weak 
activity, but are even more problematic because they tend to be promiscuous.  It has been 
shown that evolving enzymes go through a “generalist” phase in which they are 
moderately active, and after further evolution they become highly active specialists 
(Figure 3-1) (Matsumura and Ellington, 2001; Khersonsky and Tawfik, 2010).  
Selections limited by thresholding and host fitness effects may be unable to progress 
beyond the weak generalist phase, thus limiting their utility.   
 
Figure 3-1.  Activity and specialization.  
In the evolution of a new substrate specificity, an enzyme may proceed through a 
“generalist” stage.  Strong selective pressure on the new substrate pushes the substrate to 
become an active specialist.  Selections with only moderate selective pressure often give 
rise to promiscuous enzymes of moderate active.  This figure is based on data from the 
directed evolution of a hydrolase for new substrate specificity (Tokuriki et al., 2012).   
In an attempt to decouple RNA polymerase activity from host fitness, the in vivo 
autogene couples T7 RNA polymerase activity to the transcription of its own gene; thus 
more active RNA polymerases are better represented in the total mRNA population 
(Chelliserrykattil et al., 2001).  This system does not suffer the problem of thresholding, 
as there is no (theoretical) limit to the mRNA produced by a strong mutant.  However, the 
problem of metabolic overtaxing of the host is magnified by the positive feedback loop.  
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The in vitro autogene removes consideration of the host organism and should therefore be 
ideally suited for the evolution of highly active polymerases (Davidson et al., 2012).  
However, as previously discussed, the mutation rate and the limitations of the in vitro 
transcription and translation systems doomed it in practice.   
Design of the compartmentalized partnered replication platform for directed 
evolution  
The problems associated with host fitness effects, thresholding effects, and 
excessive mutation rate have hampered previous efforts to engineer T7 RNA polymerase 
promoter recognition.  The creation of an active and specific RNA polymerase should 
therefore involve a directed evolution scheme in which (1) selection is not reliant on host 
fitness, (2) increased performance scales with increased success over a wide range of 
fitness, and (3) the mutation rate can be controlled.  Compartmentalized partnered 
replication (CPR, Figure 3-2) (Ellefson et al., 2014) is such a directed evolution scheme. 
CPR couples the in vivo function of a protein, nucleic acid, operon, or circuit to its 
subsequent in vitro amplification.  In the case of the directed evolution of T7 RNA 
polymerase promoter specificity, the in vivo function is the transcription of Taq DNA 
polymerase from a synthetic promoter.  A library of T7 RNA polymerase mutants is 
transformed into E. coli cells that contain a plasmid in which the Taq DNA polymerase 
gene is directly downstream of the synthetic promoter.  Cells that are transformed with 
T7 RNA polymerase mutants capable of driving expression from the synthetic promoter 
will produce Taq DNA polymerase protein upon induction, with the most active mutants 
producing the most DNA polymerase.  Cells are then compartmentalized in a water-in-oil 
emulsion.  Each compartment is expected to contain zero or one cell as well as buffer, 
dNTPs, and primers specific to the T7 RNA polymerase gene.  Upon thermal cycling, 
cells are lysed, and their innards are released into the broader compartment.  PCR 
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amplification occurs in compartments that contain Taq DNA polymerase protein, and 
these compartments also contain the gene encoding the T7 RNA polymerase mutant 
responsible for the expression of the Taq DNA polymerase protein.  Thus, the active T7 
RNA polymerase genes are amplified by emulsion PCR while inactive ones are not. 
 
Figure 3-2.  Compartmentalized partnered replication selection scheme. 
(1) A library of T7 RNA polymerase mutants is transformed into E. coli cells containing 
the Taq DNA polymerase gene under the control of a synthetic T7 promoter variant (blue 
arrow).  Variants capable of recognizing the promoter produce Taq DNA polymerase 
protein.  (2) Whole cells are compartmentalized in a water-in-oil emulsion.  The aqueous 
droplets also contain primers, dNTPs, and Taq DNA polymerase buffer.  (3) Emulsions 
are thermal cycled, leading to cell lysis and PCR amplification of the T7 RNA 
polymerase genes that led to the production of Taq DNA polymerase during the in vivo 
step. (4)  PCR product is recovered and prepared for the next round of selection. 
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RESULTS AND DISCUSSION 
Implementation of the directed evolution of T7 RNA polymerase by CPR 
Enrichment for active T7 RNA polymerase mutants  
To demonstrate CPR as a suitable technique for the directed evolution of T7 RNA 
polymerase, three input “mock libraries” were created.  The first library was composed 
entirely of wild type T7 RNA polymerase (WT), the second was entirely composed of 
inactive T7 RNA polymerase with two premature stop codons (XX), and the third 
comprised a 10:1 mixture of XX and WT (10:1).   In each case, the T7 RNA polymerase 
open reading frame was under the control of the strong T5-lac promoter.  All three 
libraries were transformed into a Bl21 E. coli strain in which the T7 promoter (PT7) 
controlled Taq DNA polymerase expression.  Each of the three transformed populations 
was subjected to selection by CPR, with the WT and 10:1 libraries each performed under 
two different induction conditions (1.0 mM IPTG and 0.1 mM IPTG).  The primers used 
in the emulsion PCR step amplified roughly 500 base pairs, encompassing the majority of 
the fingers domain of T7 RNA polymerase.  The DNA was recovered from the emulsion 
and a portion was run on an agarose gel (Figure 3-3).  The two WT CPR recovery 
products can be easily seen, and there seems to be more product recovered when less 
IPTG is added.   This is likely because the same volume of culture (not the same number 
of cells) was added to the emulsion and because overexpressing T7 RNA polymerase, 
which then overexpresses Taq DNA polymerase, is not ideal for cell growth. The 10:1 
recovery products can only barely be seen.    
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Figure 3-3.  CPR mock selection recovery. 
Mock libraries comprising either 100% wild type T7 RNA polymerase (WT), 100% 
inactive polymerase (XX) or 90% XX and 10% WT (10:1) were subject to a single round 
of CPR.  The products of each emulsion PCR are shown.   
 The column-purified recovery products were also subject to reamplification with 
the same primers used in the emulsion PCR.   These products were analyzed by agarose 
gel electrophoresis (Figure 3-4).  The reamplification products for each reaction (even 
the negative controls) can be seen easily.  The most pronounced recovery product bands 
(Figure 3-3) give rise to the most pronounced reamplification product bands (Figure 3-4) 
suggesting that selection for active polymerases is possible.  The substantial 
reamplification product of the truncated T7 RNA polymerase genes suggests that parental 
plasmid is amplified in the reamplification PCR.  This problem is addressed in 
subsequent implementations of the selection protocol.     
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Figure 3-4.  CPR mock selection reamplification. 
The recovery products seen in Figure 3-3 were reamplified using the same primers used 
in the emulsion PCR.   
In order to determine the enrichment capability of the CPR selection, the 
reamplification products were digested with EcoRV.  The amplicon from the WT 
sequences does not contain an EcoRV recognition site, but the XX amplicon does.  
Agarose gel electrophoresis of the digested reamplification product of the 10:1 
population can therefore be used to estimate an enrichment factor (Figure 3-5).   It 
appears that roughly 90% of the digestion product corresponds to the wild type sequence.  
WT’s fecundity (ƒWT) would need to be about 90 times higher than XX’s fecundity (ƒXX) 
in order to increase from the 10% of the input to 90% of the output in a single round:   
1 * ƒWT / (10 * ƒXX + 1* ƒWT) = 0.90 or  
ƒWT = 90*ƒXX 
This implies a roughly 90-fold selective advantage of WT over XX. 
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Figure 3-5.  CPR mock selection digestion. 
The reamplification products seen in Figure 3-4 were digested with EcoRV.  The wild 
type T7 RNA polymerase (WT) sequence is undigested while the inactive T7 RNA 
polymerase (XX) sequence is cut into two distinct fragments.  The ratio of the three 
bands can be used to estimate an enrichment factor for the selection.    
 The successful enrichment of WT at the expense of XX suggests that the CPR 
selection method could be used for the evolution of T7 RNA polymerase.  Lessons 
learned in this experiment were applied to subsequent selections.  First, the induction 
strength chosen was 0.1 mM IPTG, which should reduce metabolic load and prevent 
saturation of Taq DNA polymerase production.   Second, using the same primers in the 
emulsion PCR and reamplification PCR steps results in the amplification of the parental 
plasmid in the reamplification PCR.  There are at least two possible solutions to this 
problem.  In one strategy, the emulsion PCR primers can append an extraneous sequence 
tag to each end of the amplicon and this tag can serve as the primer binding site in the 
reamplification PCR.  This strategy is employed in Chapter 5.   A second strategy, used 
in the remainder of this chapter, utilizes biotinylated primers in the emulsion PCR step 
and purification of the PCR product (away from the parental plasmid) using 
ferromagnetic beads coated with streptavidin before the reamplification.  Both strategies 
have proven to be effective.     
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Library design 
 T7 RNA polymerase makes three distinct contacts with the promoter, but the 
primary determinants of promoter specificity are made by the specificity loop (residues 
742 to 761) (Cheetham et al., 1999).  Hydrogen bonding between residues R746, N748, 
R756, and Q758 and the major groove from -7 to -11 of the promoter are especially 
critical (Raskin et al., 1993; Rong et al., 1998; Imburgio et al., 2000).  The critical R746, 
N748, R756, and Q758 residues as well as the intervening L747 and L757 were therefore 
randomized.   
 The specificity loop of T7 RNA polymerase with reduced secondary structure (T7 
RSS) was generated by PCR using a long oligodeoxynucleotide as the template.  This 
long oligodeoxynucleotide was synthesized in-house by Randall Hughes of the Ellington 
Lab on an Expedite 8900 synthesizer at a 40 nmol synthesis scale.  Degeneracy was 
introduced into the oligonucleotides at position 746 to 748 and 756 to 758 via the use of 
trimer phoshoramidites containing a mixture of 20 trimer (codon) phosphoramidites 
encoding all 20 amino acids.   
The degenerate specificity loop was used in an overlap PCR to generate the full 
length T7 RSS open reading frame.  The T7 RSS library was digested and ligated into the 
pQE backbone (in which a strong T5-lac promoter drives T7 RNA polymerase) (Ellefson 
et al., 2014).  This library serves as the basis for several selections detailed in this chapter 
and is referred to as Codon Randomized Specificity Loop Round 0 (CRSL R0). 
Selection for the use of the wild type T7 promoter  
In order to test the capability of CPR to evolve promoter recognition, a genetic 
circuit was constructed in which transcription of Taq DNA polymerase relies on T7 RNA 
polymerase binding to and activating the wild type T7 promoter (PT7). CRSL R0 was 
transformed into a strain containing this plasmid and four iterative rounds of selection by 
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CPR were performed.  The primers used in the emulsion PCR amplified roughly 500 base 
pairs.   As noted above, these primers were biotinylated, facilitating clean up after the 
emulsion was broken.  The primers used in the reamplification PCR yielded only a small 
amplicon, encompassing the randomized regions (Figure 3-6).  
 
Figure 3-6.  Sequence analysis of the T7 RNA polymerase specificity loop selection 
for the use of PT7. 
28 variants from Round 4 of the selection for the use of PT7 were sequenced.  Mismatches 
from the wild type sequence (shown near the top) are indicated by colored blocks.  The 
position weight matrix of the population is shown at the top. 
28 clones from Round 4 were sequenced and compared to the wild type RNA 
polymerase sequence (Figure 3-6).  While no perfect match to the wild type sequence 
was selected and significant diversity remained in the pool, the consensus sequence 
clearly converged on the wild type RLN…RLQ motif (R746, L747, N748 … R756, 
L757, Q758).  Clones 17 and 19 are likely inactive, while the other 26 clones are likely 
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quite active.  It should be noted that considerable diversity was retained at the non-critical 
positions L747 and L757.  
The pooled library from each round was transformed into a strain in which GFP 
expression is driven from PT7 (Figure 3-7, top).  Cultures were induced and images of 
GFP emission were taken with a digital camera (Figure 3-7, bottom).  The Round 0 
population appeared to be roughly as active as the inactive T7 RNA polymerase (XX).  
Each successive round increased in activity, with the Round 4 population having 
comparable activity to the wild type T7 RNA polymerase (WT).   
   
 
Figure 3-7.  Activity assay of the T7 RNA polymerase specificity loop selection for 
the use of PT7. 
The library from each round, as well as an inactive T7 RNA polymerase (XX) and wild 
type T7 RNA polymerase (WT) were transformed into a PT7-GFP reporter strain.  GFP 
output is a measure of activity of the round. 
Selection for the use of a synthetic T7 promoter by CPR 
Selection for the use of PCGG 
The success of the selection for recognition of the wild type promoter suggested a 
selection for the use of a synthetic promoter was possible.  A completely synthetic 
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promoter was designed with the following sequence: TAATACCGGTCACTATA.  This 
promoter, named PCGG, contains the sequence CGGT from -11 to -8.  This was decided 
upon because it quite different from PT7 (GACT) as well as the promoter of the related 
bacteriophages SP6 (GTGA), T3 (CCCT), K11 (GGCA), K1F (CTAT), and N4 (CCCA).  
It should be noted that -11 is G or C and -8 is A or T in nearly all bacteriophage 
promoters known (Rong et al., 1998; Temme et al., 2012a).  It is unclear if there is an 
evolutionary basis for this, or if it is merely a coincidence.  However, A and T were 
avoided at the -11 position and G and C were avoided at the -8 position.     
PCGG was cloned upstream of Taq DNA polymerase such that T7 RNA 
polymerase mutants that can recognize this new promoter would be preferentially 
amplified in the CPR reaction.  The Codon Randomized Specificity Loop Round 0 
(CRSL R0) was transformed into a strain containing the PCGG-Taq plasmid and rounds of 
selection using CPR were performed as above.  After seven rounds of CPR, a single 
sequence “RVH…EMQ” dominated the population (Figure 3-8, top).  A single clone 
bearing this motif (CGG-R7-8) was analyzed. The library from each round and CGG-R7-
8 were transformed into cells containing a plasmid in which GFP is driven from PCGG.  
The ability to drive GFP from PCGG was quantified using a Tecan Safire monochromator 
and compared to the fluorescence output of wild type T7 RNA polymerase driving GFP 
from PT7.   The activity of the CGG-R7-8:PCGG pair was equivalent to only about 2% of 
the activity of wild type T7 RNA polymerase:PT7 (WT:PT7) pair (Figure 3-8, bottom 
left).  In an assay for cross-reactivity, only background levels of fluorescence for the 
WT:PCGG and CGG-R7-8:PT7 pairs were seen (Figure 3-8, bottom right).   
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Figure 3-8.  Analysis of Round 7 of the T7 RNA polymerase specificity loop selection 
for the use of PCGG. 
Top) 14 variants from Round 7 of the selection for the use of PCGG were sequenced.   
Mismatches from the wild type sequence (shown at the top) are indicated by colored 
blocks.  Bottom left) The library from each round of the PCGG selection, as well as CGG-
R7-8 were transformed into a PCGG-GFP reporter strain.  GFP output / OD600 is a 
measure of activity of the round, relative to the activity of the WT:PT7 pair.  Values are 
the average from three independent cultures; error bars represent standard error. Bottom 
right) Wild type T7 RNA polymerase and CGG-R7-8 were transformed into PCGG-GFP 
and PT7-GFP reporter lines.  Cells were grown, induced, and imaged to obtain a visual 
depiction of activity and cross-reactivity.   
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Maturation of CGG-R7-8 
The modest activity of CGG-R7-8 suggested that additional T7 RNA polymerase 
mutations, not present in the initial library, were needed to allow the polymerase to 
recognize the synthetic promoter sequence.  To further improve the activity of the CGG-
R7-8 polymerase on the PCGG promoter, an additional five rounds of selection by CPR 
were performed.  In these rounds the reamplification PCR was performed with primers 
that yielded a larger amplicon (about 500 base pairs) flanking the specificity loop and 
encompassing much of the fingers domain.  This allowed the entire promoter specificity 
domain to evolve, instead of being held constant.  Additionally this larger region of was 
subjected to random mutagenesis via error-prone PCR before the first and fourth 
additional rounds.  
The Round 12 population was transformed into the PCGG-GFP reporter strain and 
the activity (GFP fluorescence / OD600) of 93 clones were quantified.   The eight T7 
RNA polymerase variants that drove the highest GFP expression from PCGG were 
sequenced (Figure 3-9).  
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Figure 3-9.  Sequence analysis of Round 12 of the T7 RNA polymerase specificity 
loop selection for the use of PCGG. 
The library from Round 12 of the selection for the use of PCGG was transformed into a 
PCGG-GFP reporter strain.  Individual clones were measured for GFP fluorescence, and 
the eight most fluorescent variants were sequenced. The “RVH…EMQ” motif remained 
invariant.  Clone 3 was the most active, and was renamed CGG-R12-KI.  The mutations 
Q744K (“K”), L749I (“I”), E768G (“G”), H772R (“R”), and E775V (“V”) appeared in 
multiple clones. 
The most active T7 RNA polymerase variant from this population, CGG-R12-KI, 
displayed 20% the activity of the WT:PT7 pair (Figure 3-10).  Additional mutations 
beyond those seen in CGG-R12-KI were also frequently observed in variants in the 
Round 12 population (Figure 3-9).  Specifically, the mutations Q744K (“K”), L749I 
(“I”), E768G (“G”), H772R (“R”), and E775V (“V”) appeared in multiple variants.  
Combinations of these frequently occurring mutations were embedded into the CGG-R7-
8 sequence.  The resulting mutants were assayed for activity in the PCGG-GFP strain and 
several mutants showed even further enhancement: 40-60% activity of the WT:PT7 pair.   
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Figure 3-10.  In vivo activity assay for the use of PCGG. 
The library from each round of the selection for the use of PCGG, as well as various 
described mutants were transformed into a PCGG-GFP reporter strain.  GFP fluorescence 
(in Relative Fluorescence Units) / OD600 is a measure of the activity of each 
polymerase:promoter pair relative to the activity of the WT:PT7 pair, defined as 100.  
Values are the average from three independent cultures; error bars represent standard 
error. 
The five most active variants (CGG-R12-KIV, CGG-R12-KIR, CGG-R12-KIRV, 
CGG-R12-KIGR, and CGG-R12-KIGRV) were mixed in equal ratios and selected by 
CPR for an additional four rounds (with error-prone PCR before the first, third, and 
fourth round).  The resulting Round 16 population closely resembled the mutant CGG-
R12-KIRV, with no additional consensus mutations.  The selection was therefore judged 
to be complete. 
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Characterization of CGG-R12-KIRV 
In order to judge the success of the selection, CGG-R12-KIRV was tested for 
activity and cross-reactivity in vivo.   A plasmid expressing the mutant enzyme was 
transformed into a PCGG-GFP reporter strain as well as a PT7–GFP reporter strain (Figure 
3-11).  The CGG-R12-KIRV:PCGG pair demonstrated roughly 30% activity (GFP 
fluorescence/OD600) as compared to the WT:PT7 pair.  In terms of cross-reactivity, the 
CGG-R12-KIRV:PT7 and WT:PCGG pairs demonstrated only about 1% activity.   
 
Figure 3-11.  In vivo activity and cross-reactivity assay of CGG-R12-KIRV. 
Wild type T7 RNA polymerase and CGG-R12-KIRV were transformed into PCGG-GFP 
and PT7-GFP reporter lines.  Left) Cells were grown, induced, and imaged to obtain a 
visual depiction of activity and cross-reactivity.  Right) GFP fluorescence (in Relative 
Fluorescence Units) / OD600 is a measure of the activity of each polymerase:promoter 
pair relative to the activity of the WT:PT7 pair, defined as 100.  Values are the average 
from three independent cultures; error bars represent standard error.  
Both the wild type T7 RNA polymerase and CGG-R12-KIRV were expressed and 
purified.  The enzymes were assayed in vitro for transcriptional activity on both PT7 and 
PCGG.  For each template, the promoter was followed by the fluorescent aptamer Spinach 
(Paige et al., 2011).  Transcriptions were performed on a Tecan Safire monochromator 
and fluorescence readings were taken every minute.  Fluorescent output is used as a real-
time indication of transcriptional activity.  This assay has proven to be a facile and 
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reliable method to judge RNA polymerase activity.  The real-time measurements prevent 
signal saturation, which can be a limitation with traditional end-point measurements.  The 
results of this in vitro assay are comparable to the in vivo data, with CGG-R12-KIRV 
showing roughly 60% on-target activity less than 0.1% cross-reactivity (Figure 3-12).  
The reduction in apparent off-target activity in vitro (as compared to in vivo cross-
reactivity) suggests that the measured in vivo cross-reactivity is on par with the 
background fluorescence of E. coli. 
 
Figure 3-12.  In vitro activity and cross-reactivity assay of CGG-R12-KIRV. 
Wild type T7 RNA polymerase and CGG-R12-KIRV were used in an in vitro 
transcription assay using PT7 and PCGG-driven expression of the Spinach aptamer as a 
readout.  Spinach fluorescence (in Relative Fluorescence Units) is a measure of the 
activity of each polymerase:promoter pair relative to the activity of the WT:PT7 pair, 
defined as 100.  Values are the average from three independent reactions; error bars 
represent standard error. 
Comparison of CGG-R12-KIRV to other T7 RNA polymerase promoter specificity 
mutants 
In order to demonstrate the quality of CGG-R12-KIRV and the utility of CPR as a 
method for the directed evolution of protein function, CGG-R12-KIRV was compared to 
the engineered polymerases from the literature reported to have the highest activity and 
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specificity.  The comparable polymerases’ method of generation, sequence, preferred 
promoter, and reported activity and specificity are summarized in Table 3-1.   
 
Table 3-1.  Comparison of T7 RNA polymerase promoter specificity mutants. 
Underlined sequences denote deviation from the wild type CGACT promoter motif.  The 
* denotes that the promoter varies from PT7 outside of the -12 to -8 range.  Specifically, 
“GCCGA*” is AATTAGCCGACACTAAAGAAGAA and “ACCCT*” is 
AATTAACCCTCACTAAAGGGAGA from -17 to +6.  Mutant polymerase activity 
refers to the activity of the mutant polymerase on the mutant promoter (relative to the 
wild type pair defined as 100).   Mutant orthogonality refers to the ratio of the mutant 
activity on its cognate promoter to its activity on the wild type promoter.  Bold data are 
from in vitro assays. 
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Based on the reported characteristics of previously evolved or designed T7 RNA 
polymerase promoter specificity mutants, CGG-R12-KIRV compares well in terms of 
specificity but not in terms of activity.  However, since the methods used to characterize 
the polymerases are not consistent with each other or with the above characterizations, it 
was necessary to provide a side by side comparison of all the listed polymerases to CGG-
R12-KIRV.   
 First, an in vivo activity and cross-reactivity assay was conducted.  Each 
polymerase was transformed into its own specific Pcog-GFP strain (where Pcog, is the 
cognate promoter for each polymerase) as well as the PT7-GFP reporter strain.  Wild type 
T7 RNA polymerase (WT) was also transformed into each reporter line.  The activity of 
each polymerase with its cognate promoter, WT’s activity with the same promoter, the 
mutant activity with PT7 and the activity of the WT:PT7 pair is visualized and quantified 
with GFP fluorescence (Figure 3-13 and Figure 3-14).   
 
Figure 3-13.  In vivo activity and cross-reactivity assay of T7 RNA polymerase 
promoter specificity mutants. 
Wild type T7 RNA polymerase and a range of mutants were transformed into several 
GFP reporter lines.  Cells were grown, induced, and imaged to obtain a visual depiction 
of activity and cross-reactivity. 
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Figure 3-14.  Quantitative in vivo activity and cross-reactivity assay of T7 RNA 
polymerase promoter specificity mutants. 
Wild type T7 RNA polymerase and a range of mutants were transformed into several 
GFP reporter lines to quantify activity and cross-reactivity.  “Polymerase cross reactivity” 
(black) refers to the activity of the mutant T7 RNA polymerase on the wild type 
promoter.  “Promoter cross reactivity” (grey) refers to the activity of wild type T7 RNA 
polymerase on the mutant promoter.  “Polymerase:promoter activity” (blue) refers to the 
activity of the mutant polymerase on the mutant promoter.  GFP fluorescence (in Relative 
Fluorescence Units) / OD600 is a measure of the activity of each polymerase:promoter 
pair relative to the activity of the WT:PT7 pair, defined as 100.  Values are the average 
from three independent cultures; error bars represent standard error.  
 Assaying reported polymerases using consistent parameters revealed that CGG-
R12-KIRV is one of the most active RNA polymerases described, with only Q758C 
being comparable.  It should be noted that several polymerases in the literature with 
activities reported to be greater than wild type are either inactive (SP6-192-3-8 and SP6-
192-4-2) or only weakly active (L1-108.1 and T7(N4)).  It is likely that the discrepancies 
between reported and observed activity are due to toxicity.  That is, polymerases are 
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assayed by being overexpressed and subsequently overexpressing a reporter. Apparent 
activity can be obscured due to a very active polymerase (such as the wild type pair) 
appearing inactive because it overtaxes its host, leading to mutation, cell sickness, or 
death (Shis and Bennett, 2013).  In some cases, the promoter and RBS driving the 
polymerase was allowed to evolve and was retained during the assay.  Therefore the 
expression of each polymerase was unequal, thus skewing the observed activity of each 
polymerase (Dickinson et al., 2013).  In the case of T7(T3), T7(K1F), and T7(N4) (which 
had been generated by domain grafting) the RBS and active site of wild type T7 RNA 
polymerase were mutated before the assay, inviting a false comparison between mutant 
and wild type (Temme et al., 2012a).    
 To further demonstrate orthogonality, the most active polymerases from the GFP 
assays were transformed into a cell line in which PheS A294G is under the control of the 
T7 promoter.  PheS A294G is a promiscuous mutant of the phenylalanine aminoacyl-
tRNA synthetase (Kast and Hennecke, 1991; Thyer et al., 2013).  Alone, PheS A294G 
has no observable effect on E. coli.  However, in the presence of the unnatural amino acid 
4-chloro-DL-phenylalanine (Cl-Phe), PheS A294G charges phenylalanine tRNAs with 
Cl-Phe, leading to random translational errors of the proteome and subsequently cell 
death.  Cultures were grown, induced, and dilution-plated on a range of Cl-Phe 
concentrations (Figure 3-15).  Cross-reactivity can be judged by the dose dependent 
cytotoxicity of Cl-Phe.  CGG-R12-KIRV forms the same number of colonies at 20 mM 
Cl-Phe as with no Cl-Phe.  All other mutants show a marked decrease in colony 
formation at 5 to 15 mM Cl-Phe.  The data from this cell toxicity assay are in fine 
agreement with the GFP assay and indicate that CGG-R12-KIRV is much more 
orthogonal to PT7 than any other tested T7 RNA polymerase specificity mutant.   
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Figure 3-15.  In vivo orthogonality of T7 RNA polymerase promoter specificity 
mutants. 
Wild type T7 RNA polymerase and a range of mutants were transformed into a reporter 
line in which PheS A294G, is driven by PT7.   Cultures were induced with 0.05 mM IPTG 
before being diluted to an OD600 of 0.1, 0.01, and 0.001.  Dilutions were plated on 
media containing 0, 5, 10, 15, or 20 mM Cl-Phe.  RNA polymerase variants driving PheS 
A294G from PT7 are expected to die in the presence of Cl-Phe. 
As a final measure of activity and specificity, each previously published 
polymerase was expressed, purified, and assayed in vitro.   Each polymerase was allowed 
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to transcribe the fluorescent aptamer Spinach from its cognate promoter or PT7.  Wild 
type T7 RNA polymerase was also allowed to transcribe Spinach from each promoter.  
Measurements of fluorescence were taken every two minutes.  The fluorescent reading 
for each polymerase: polymerase promoter pair was analyzed after 30 minutes (enough 
time to overcome the initial background fluorescence, but prior to signal saturation) 
(Figure 3-16).   The trends are consistent with the in vivo assays, with CGG-R12-KIRV 
being the most specific and among the most active polymerases (Table 3-2).  Taken 
together, these data suggest that CGG-R12-KIRV is the most successful attempt at 
engineering T7 RNA polymerase promoter specificity to date.  More broadly, the 
successful evolution of a highly active and specific T7 RNA polymerase promoter 
specificity mutant highlights the usefulness of CPR as a method for the evolution of 
enzyme activity and specificity.  
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Figure 3-16.  In vitro activity and cross-reactivity assay of T7 RNA polymerase 
promoter specificity mutants. 
Wild type T7 RNA polymerase and a range of mutants were used in an in vitro 
transcription assay.  PT7 or mutant promoter driven expression of the Spinach aptamer 
was used as a readout to quantify activity and cross-reactivity.  “Polymerase cross 
reactivity” (black) refers to the activity of the mutant T7 RNA polymerase on the wild 
type promoter.  “Promoter cross reactivity” (grey) refers to the activity of wild type T7 
RNA polymerase on the mutant promoter.  “Polymerase:promoter activity” (blue) refers 
to the activity of the mutant polymerase on the mutant promoter.  Spinach fluorescence 
(in Relative Fluorescence Units) is a measure of the activity of each polymerase:promoter 
pair relative to the activity of the WT:PT7 pair, defined as 100.  Values are the average 
from three independent reactions; error bars represent standard error.  
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Table 3-2.  Comparison of T7 RNA polymerase promoter specificity mutants. 
“Activity” refers to the activity of the mutant polymerase on the mutant promoter 
(relative to the wild type pair defined as 100).   “Orthogonality” refers to the ratio of the 
mutant activity on its cognate promoter to its activity on the wild type promoter.  Bold 
data are from in vitro assays.  Reported activity and orthogonality is taken from data in 
the literature (or Figures 3-11 and 3-12 for CGG-R12-KIRV).  Measured activity and 
orthogonality are taken from data presented in Figures 3-14 and 3-16.   
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Directed evolution of a panel of orthogonal T7 RNA polymerase:promoter pairs 
Selection for the use of PCTGA 
To increase the number of available, mutually orthogonal T7 RNA polymerase 
variants, an attempt was made to alter the molecular recognition of T7 RNA polymerase 
to drive transcription from another novel promoter, PCTGA.  This promoter was chosen 
because it is different from the wild type T7 promoter at all four of the most critical base 
pairs (-11 to -8).  It is also different from the most orthogonal existing promoters (PCGG, 
PT3, PK1F, and PN4) at two or more of those positions.   
A construct was generated in which PCTGA drives Taq DNA polymerase, and a 
strain carrying this plasmid was transformed with the Round 0 population used 
previously (CRSL R0).  This library began to converge on active sequences after four 
rounds of selection by CPR.  After seven rounds the library was dominated by a single 
variant (termed CTGA-R7-1 (Figure 3-17) that had the sequence L747I, N748T, R756T, 
Q758K.  In order to further ascertain the functionality of CTGA-R7-1 an expression 
construct for the polymerase was transformed into an E. coli strain that also carried a 
GFP gene coupled to the PCTGA promoter (Figure 3-17).  CTGA-R7-1 produced about 
1% as much GFP from PCTGA as the wild type T7 RNA polymerase produced from PT7.   
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Figure 3-17.  Analysis of Round 7 of the T7 RNA polymerase specificity loop 
selection for the use of PCTGA. 
Seven variants from Round 7 of the selection for the use of PCTGA were sequenced.  
Mismatches from the wild type sequence (shown at the top) are indicated by colored 
blocks. CTGA-R7-1 was transformed into a PCTGA-GFP reporter line.  GFP fluorescence 
(in Relative Fluorescence Units) / OD600 is a measure of the activity the 
polymerase:promoter pair relative to the activity of the WT:PT7 pair, defined as 100.  
Values are the average from three independent cultures; error bars represent standard 
error.  
The weak activity of CTGA-R7-1 was in line with the generally low efficiency 
seen by CGG-R7-8.  It was therefore hypothesized that further mutations in the regions 
flanking the promoter specificity determinants would provide substantive improvements 
in activity.    As before, a larger region (amino acid residues 663 to 793) was subjected to 
error-prone PCR and CPR optimization.  After six further rounds of selection (with error-
prone PCR at Rounds 8, 10, 11, and 13) some 288 clones from the library were assayed 
for in vivo GFP expression from PCTGA.  Active clones (judged by fluorescence readings) 
were sequenced, and several mutations were found to occur frequently in the population, 
namely, I681L, Q744K, H772R, E775V and to a lesser extent V725A, T748S, and L749I, 
(Figure 3-18).   
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Figure 3-18.  Sequence analysis of Round 13 of the T7 RNA polymerase specificity 
loop selection for the use of PCTGA. 
The library from Round 13 of the selection for the use of PCTGA was transformed into a 
PCTGA-GFP reporter strain.  Individual clones were measured for GFP fluorescence, and 
the 32 most fluorescent variants were sequenced.  Wild type T7 RNA polymerase 
sequence is shown at the top.   Mismatches from the CTGA-R7-1 polymerase sequence 
(shown near the top) are indicated by colored blocks.   Residues 633 to 793 are shown. 
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Different combinations of the selected mutations were added to the original 
CTGA-R7-1 variant, and then assayed for activity in the PCTGA-GFP strain (Figure 3-19).  
The clone CTGA-R13-AKSRV that contained the mutations V725A, Q744K, T748S, 
H772R, E775V on top of the parental CTGA-R7-1 (L747I, N748T, R756T, Q758K) was 
found to be highly active, demonstrating 43.5% activity on PCTGA relative to the wild type 
combination. 
 
Figure 3-19.  In vivo activity assay for the use of PCTGA. 
Various combinations of consensus mutations were added to CTGA-R7-1. These mutants 
were transformed into a PCTGA-GFP reporter strain.  GFP fluorescence (in Relative 
Fluorescence Units) / OD600 is a measure of the activity of each polymerase with PCTGA 
relative to the activity of the WT:PT7 pair, defined as 100.  Values are the average from 
three independent cultures; error bars represent standard error. 
Selection for the use of PT3, PK1F, and PN4 
T7 RNA polymerase variants capable of utilizing PT3, PK1F, and PN4 promoters 
have been described above (Table 3-1).  T7(T3), T7(K1F), T7(N4) were made by 
grafting the promoter specificity loop from related bacteriophage encoded polymerases 
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onto the T7 RNA polymerase scaffold (Temme et al., 2012a).  Upon initial testing it was 
discovered that while these polymerases were relatively specific for their respective 
promoters, their overall activity was low.  Each polymerase displayed only about 1-10% 
of the in vivo activity of the wild type polymerase:promoter pair (Figures 3-13, 3-14, 3-
15, and Table 3-2).  This is perhaps because the grafted promoter specificity loops are 
not oriented to the promoter with the optimal geometry.  Even though it is remarkable 
that such grafting was able to confer specificity, the differences in the structural context 
likely limited activity.  It was therefore hypothesized that the activity could be improved 
by directed evolution.    
Each polymerase variant was subject to five rounds of CPR (with error-prone 
PCR prior to Rounds 1, 3 and 5).  As above, the final population was subjected to a GFP-
based screen, consensus mutations were determined (Figures 3-20, 3-21 and 3-22), and 
combinatorial mutants were generated and assayed (Figures 3-23, 3-24 and 3-25).  The 
most active variants from each selection were:  T3-R5-RRVH (T745K, N748D, L749M, 
M750I, G753R, H772R, E775V, Q786H); K1F-R5-KIKR (Q744K, L749I, M750K, 
Q754S, R756N, I761V, H772R); and N4-R5-YRNRV (N671Y, L747I, N748D, L749C, 
M750V, F751I, Q754T, F755R, L757M, Q758A, P759L, D770N, H772R, E775V) 
(Table 3-3).  These variants demonstrated 182.0%, 78.6%, and 22.2% activity in 
comparison to wild type T7 RNA polymerase with its promoter, which were respectively 
20-, 119-, and 91-fold improvements over the parental enzymes.   
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Figure 3-20.  Sequence analysis of Round 5 of the selection for the use of PT3. 
The library from Round 5 of the selection for the use of PT3 was transformed into a PT3-
GFP reporter strain.  Individual clones were measured for GFP fluorescence, and the 32 
most fluorescent variants were sequenced.  Wild type T7 RNA polymerase sequence is 
shown at the top.  Mismatches from the T7(T3) polymerase sequence (shown near the 
top) are indicated by colored blocks.   Residues 633 to 793 are shown. 
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Figure 3-21.  Sequence analysis of Round 5 of the selection for the use of PK1F. 
The library from Round 5 of the selection for the use of PK1F was transformed into a PK1F-
GFP reporter strain.  Individual clones were measured for GFP fluorescence, and the 10 
most fluorescent variants were sequenced.  Wild type T7 RNA polymerase sequence is 
shown at the top.  Mismatches from the T7(K1F) polymerase sequence (shown near the 
top) are indicated by colored blocks.   Residues 633 to 793 are shown. 
 
Figure 3-22.  Sequence analysis of Round 5 of the selection for the use of PN4. 
The library from Round 5 of the selection for the use of PN4 was transformed into a PN4-
GFP reporter strain.  Individual clones were measured for GFP fluorescence, and the 13 
most fluorescent variants were sequenced.  Wild type T7 RNA polymerase sequence is 
shown at the top.  Mismatches from the T7(N4) polymerase sequence (shown near the 
top) are indicated by colored blocks.   Residues 633 to 793 are shown. 
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Figure 3-23.  In vivo activity assay for the use of PT3. 
Various combinations of consensus mutations were added to T7(T3). These mutants were 
transformed into a PT3-GFP reporter strain.  GFP fluorescence (in Relative Fluorescence 
Units) / OD600 is a measure of the activity of each polymerase with PT3 relative to the 
activity of the WT:PT7 pair, defined as 100.  Values are the average from three 
independent cultures; error bars represent standard error. 
 
Figure 3-24.  In vivo activity assay for the use of PK1F. 
Various combinations of consensus mutations were added to T7(K1F). These mutants 
were transformed into a PK1F-GFP reporter strain.  GFP fluorescence (in Relative 
Fluorescence Units) / OD600 is a measure of the activity of each polymerase with PK1F 
relative to the activity of the WT:PT7 pair, defined as 100.  Values are the average from 
three independent cultures; error bars represent standard error. 
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Figure 3-25.  In vivo activity assay for the use of PN4. 
Various combinations of consensus mutations were added to T7(N4). These mutants were 
transformed into a PN4-GFP reporter strain.  GFP fluorescence (in Relative Fluorescence 
Units) / OD600 is a measure of the activity of each polymerase with PN4 relative to the 
activity of the WT:PT7 pair, defined as 100.  Values are the average from three 
independent cultures; error bars represent standard error. 
Assay of the most active mutant from each selection 
It was hypothesized that selecting for very active variants would, in turn, lead to 
very specific variants, based on previous studies (Matsumura and Ellington, 2001; 
Tokuriki et al., 2012).  For example, Tawfik and colleagues showed that as a hydrolase 
gained activity with a new substrate, it also gained specificity towards that substrate 
relative to the original substrate (Tokuriki et al., 2012).  Each of the five variant 
polymerases, and the wild type T7 RNA polymerase was tested against each of the five 
cognate promoters and PT7 (6 x 6 in total).  Each polymerase was separately transformed 
into six distinct cell lines in which the six different promoters drove the production of 
GFP (Figure 3-26 and 3-27, Table 3-3).  While no polymerase showed less than 3.3-fold 
selectivity for its cognate promoter over any other promoter, there were several cases of 
cross-reactivity.  Specifically, T3-R5-RRVH was quite cross-reactive with PT7, showing 
only an 8.8-fold preference for PT3.  Similarly, K1F-R5-KIKR prefers PK1F by only 3.3-
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fold over PT7 and 6.1-fold over PT3.  All other polymerase variants utilize their cognate 
promoters with at least 10-fold specificity, making them among the most orthogonal 
polymerases ever created by enzyme engineering.   
 
Figure 3-26.  In vivo activity and cross-reactivity assay of the most active T7 RNA 
polymerase mutants from each selection. 
The most active variant from each selection was transformed into each of six different E. 
coli strains, which contain the GFP gene under the control of one of the six T7 promoter 
variants.  Cells were grown, induced, and imaged to obtain a visual depiction of activity 
and cross-reactivity. 
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Figure 3-27.  Quantitative in vivo activity and cross-reactivity assay of the most 
active T7 RNA polymerase mutants from each selection. 
The most active variant from each selection was transformed into each of six different E. 
coli strains, which contain the GFP gene under the control of one of the six T7 promoter 
variants.  GFP fluorescence (in Relative Fluorescence Units) / OD600 is a measure of the 
activity of each polymerase:promoter pair relative to the activity of the WT:PT7 pair, 
defined as 100.  Values are the average from three independent cultures; error bars 
represent standard error.  
.   
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Table 3-3.  A list of the most active T7 RNA polymerase promoter specificity 
mutants from each selection. 
The name, sequence, and preferred promoter of the most active T7 RNA polymerase 
mutant from each selection are shown.   “Activity on cognate” data are taken from (in 
vivo) experiments depicted in Figures 3-10, 3-19, 3-23, 3-24, 3-25, 3-26, 3-27, 3-28, 3-
29, 3-30, 3-31, 3-32.  They are the average of three different experiments (each in 
triplicate) on three different days.    
Cross-reactivity assays 
Comparison of the data in Figure 3-26 and Figure 3-14 suggests that the most 
active polymerases from each selection are also more orthogonal than most previously 
described polymerases.  However, while it is reasonable to believe that selecting and 
screening for highly active mutants can yield highly specific mutants, some mutations 
that improve efficiency do so via non-specific mechanisms (for example, by forming an 
interaction with the phosphate backbone).  Therefore, the previously generated panel of 
variants from each selection was rescreened not only for their ability to drive GFP 
production  from their cognate promoters but also for their cross-reactivity.  In each case, 
several additional candidates that were very active yet less cross-reactive were obtained.   
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The mutants from the PCGG selection were tested against PCGG, as well as PT7 and 
PT3 (Figure 3-28).  CGG-R12-KIR (Q744K, L747V, N748H, L749I, R756E, L757M, 
H772R) was 26.0% active with PCGG and had at least a 36.4-fold selectivity over PT7 and 
PT3 (compared to 28.5-fold for CGG-R12-KIRV.)  
 
Figure 3-28.  In vivo cross-reactivity assay of T7 RNA polymerase mutants from the 
PCGG selection. 
The mutants from the PCGG selection were transformed into reporter strains in which GFP 
was driven by PT7, PCGG, or PT3.  GFP fluorescence (in Relative Fluorescence Units) / 
OD600 is a measure of the activity of each polymerase:promoter pair relative to the 
activity of the WT:PT7 pair, defined as 100.  Values are the average from three 
independent cultures; error bars represent standard error. 
The mutants from the PCTGA selection were tested against PCTGA, as well as PT7 
and PCGG (Figure 3-29).  CTGA-R13-AKSIRV (V725A, Q744K, L747I, N748S, L749I, 
R756T, Q758K, H772R, E775V) was 17.0% active with PCTGA and had at least a 40.5-
fold selectivity over PT7 and PCGG (compared to 15.2-fold for CTGA-R13-AKSRV.)  
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Figure 3-29.  In vivo cross-reactivity assay of T7 RNA polymerase mutants from the 
PCTGA selection. 
The mutants from the PCTGA selection were transformed into reporter strains in which 
GFP was driven by PT7, PCGG, or PCTGA.  GFP fluorescence (in Relative Fluorescence 
Units) / OD600 is a measure of the activity of each polymerase:promoter pair relative to 
the activity of the WT:PT7 pair, defined as 100.  Values are the average from three 
independent cultures; error bars represent standard error. 
The mutants from the PT3 selection were tested against PT3, as well as PT7 (Figure 
3-30).  T3-R5-RV (T745K, N748D, L749M, M750I, H772R, E775V) was 34.1% active 
with PT3 and had at least a 46.2-fold selectivity over PT7 (compared to 4.5-fold for T3-R5-
RRVH.)  
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Figure 3-30.  In vivo cross-reactivity assay of T7 RNA polymerase mutants from the 
PT3 selection. 
The mutants from the PT3 selection were transformed into reporter strains in which GFP 
was driven by PT7 or PT3.  GFP fluorescence (in Relative Fluorescence Units) / OD600 is 
a measure of the activity of each polymerase:promoter pair relative to the activity of the 
WT:PT7 pair, defined as 100.  Values are the average from three independent cultures; 
error bars represent standard error. 
The mutants from the PK1F selection were tested against PK1F, as well as PT7, PCGG, 
and PT3 (Figure 3-31).  K1F-R5-IRH (L749I, Q754S, R756N, I761V, H772R, Q786H) 
was 19.5% active with PK1F and had at least a 10.6-fold selectivity over PT7, PCGG, and PT3 
(compared to 4.2-fold for K1F-R5-KIKR.)  
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Figure 3-31.  In vivo cross-reactivity assay of T7 RNA polymerase mutants from the 
PK1F selection. 
The mutants from the PK1F selection were transformed into reporter strains in which GFP 
was driven by PT7, PCGG, PT3, or PK1F.  GFP fluorescence (in Relative Fluorescence Units) 
/ OD600 is a measure of the activity of each polymerase:promoter pair relative to the 
activity of the WT:PT7 pair, defined as 100.  Values are the average from three 
independent cultures; error bars represent standard error. 
The mutants from the PN4 selection were tested against PN4, as well as PT3 (Figure 
3-32).  N4-R5-RNRV (L747I, N748D, L749C, M750V, F751I, Q754T, F755R, L757M, 
Q758A, P759L, D770N, H772R, E775V) was 13.0% active with PN4 and had at least an 
8.5-fold selectivity over PT3 (compared to 8.1-fold for N4-R5-YRNRV.)  
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Figure 3-32.  In vivo cross-reactivity assay of T7 RNA polymerase mutants from the 
PN4 selection. 
The mutants from the PN4 selection were transformed into reporter strains in which GFP 
was driven by PT3 or PN4.  GFP fluorescence (in Relative Fluorescence Units) / OD600 is 
a measure of the activity of each polymerase:promoter pair relative to the activity of the 
WT:PT7 pair, defined as 100.  Values are the average from three independent cultures; 
error bars represent standard error. 
Assay of the most specific mutant from each selection 
In order to confirm the orthogonality of these polymerase:promoter pairs in vivo, 
each polymerase was again assayed with the set of six promoters.  As above, each 
polymerase was separately transformed into six distinct cell lines in which the six 
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different promoters drove the production of GFP.  Visual analysis indicates that this new 
panel of polymerases is, in fact, truly orthogonal (Figure 3-33).   
 
Figure 3-33.  In vivo activity and cross-reactivity assay of the most specific T7 RNA 
polymerase mutants from each selection.  
The most active variant from each selection/screen was transformed into each of six 
different E. coli strains, which contain the GFP gene under the control of one of the six 
T7 promoter variants.  Cells were grown, induced, and imaged to obtain a visual 
depiction of activity and cross-reactivity. 
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Quantitative measurement of the activity and cross-reactivity of these 
polymerases showed that they ranged from 15.6 to 43.5% activity on their respective 
cognate promoter and no polymerase showed more than 2.5% activity on a non-cognate 
promoter (Figure 3-34).   
 
Figure 3-34.  Quantitative in vivo activity and cross-reactivity assay of the most 
specific T7 RNA polymerase mutants from each selection. 
The most specific variant from each selection was transformed into each of six different 
E. coli strains, which contain the GFP gene under the control of one of the six T7 
promoter variants.  GFP fluorescence (in Relative Fluorescence Units) / OD600 is a 
measure of the activity of each polymerase:promoter pair relative to the activity of the 
WT:PT7 pair, defined as 100.  Values are the average from three independent cultures; 
error bars represent standard error.  
It can be misleading to judge the quality of evolved proteins in a context similar 
to the conditions under which they evolved.  To demonstrate that CPR did not just yield 
polymerases that were active and orthogonal in vivo, each polymerase was purified and 
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assayed for its ability to drive the transcription of the fluorescent aptamer Spinach from 
each promoter (Figure 3-35).  As before, fluorescence readings were recorded as a 
measure of transcriptional activity, and thus as an indicator of promoter recognition in 
vitro.  The evolved polymerases again showed high activity with their cognate promoters 
(ranging from 33% to 64% activity, relative to wild type T7 RNA polymerase with its 
cognate promoter) and have excellent specificity (13.5- to 45.8-fold preferences for their 
respective cognate promoters). 
 
Figure 3-35.  In vitro activity and cross-reactivity assay of the most specific T7 RNA 
polymerase mutants from each selection. 
The most specific variant from each selection were used in an in vitro transcription assay.  
PT7 or mutant promoter driven expression of the Spinach aptamer was used as a readout 
to quantify activity and cross-reactivity.  Spinach fluorescence (in Relative Fluorescence 
Units) is a measure of the activity of each polymerase:promoter pair relative to the 
activity of the WT:PT7 pair, defined as 100.  Values are the average from three 
independent reactions; error bars represent standard error.  
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This panel of orthogonal T7 RNA polymerase promoter specificity mutants 
demonstrates a high degree of activity and specificity for their respective cognate 
promoters.  Their characteristics are summarized in Table 3-4.   
 
Table 3-4.  A list of the most specific T7 RNA polymerase promoter specificity 
mutants from each selection. 
The name, sequence, and preferred promoter of the most specific T7 RNA polymerase 
mutant from each selection are shown.  “In vivo activity” data are taken from the 
experiments depicted in Figures 3-10, 3-19, 3-23, 3-24, 3-25, 3-28, 3-29, 3-30, 3-31, 3-
32, 3-33, and 3-34.  They are average of three different experiments (each in triplicate) 
on three different days.  “In vivo orthogonality” data are taken from the experiments 
depicted in Figures 3-28, 3-29, 3-30, 3-31, 3-32, 3-33, and 3-34.  They are average of 
two different experiments (each in triplicate) on two different days.   “In vitro activity” 
and “in vitro orthogonality” data are taken from the experiment depicted in Figure 3-35.  
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CONCLUSION 
The orthogonal T7 RNA polymerase specificity mutants described in this chapter 
are among the most active and by far the most specific ever generated by enzyme 
engineering.  Even the least active and specific enzyme (N4-R5-RNRV) is on par with 
any other engineered polymerase.   
The “hexacore” set of polymerases described above will be the standard for the 
field for either modular control of multiple pathways or parallel processing of nucleic 
acid computation.  For applications requiring two orthogonal pairs, the WT:PT7 and 
CGG-R12-KIR:PCGG set is the best option, as they are highly orthogonal to each other.  If 
further pairs are required, the best option would be the addition of N4-R5-RNRV:PN4, 
followed by the CTGA-R13-AKSIRV:PCTGA pair .   
The T3-R5-RV may be too cross-reactive with PT7, and K1F-R5-IRH may be too 
cross-reactive with PT7 and PT3 to be useful if a high degree of orthogonality is required.  
However, since wild type T7 RNA polymerase is so active, this problem could be 
addressed by “weakening” PT7 and PT3.  For example, a T-2A mutation could be expected 
to reduce the activity of all polymerases on a given promoter by two-fold (Imburgio et 
al., 2000; Temme et al., 2012a, 2012b).   This could bring the activity of WT:PT7 down to 
the level of the other polymerase:cognate-promoter pairs, and reduce the apparent cross-
reactivity of the other polymerases with PT7.   
The quality of the evolved polymerase:promoter pairs underscores the value of 
directed evolution in general and CPR in particular.  The methodology employed to 
create the libraries used to make polymerase that recognize PCGG and PCTGA took 
structural and mutational studies into consideration, and all residues thought to be 
important were randomized.  Yet, the winners of the selections (CGG-R7-8 and CTGA-
R7-1) were only weakly active.  It took random mutagenesis to uncover mutations that 
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allowed robust activity to emerge.  Similarly, T7(T3), T7(K1F), and T7(N4) were made 
with phylogenetic and structure considerations taken into account, yet they were also 
improved by random mutagenesis and selection.  Taken together, these instances suggest 
that protein:DNA interactions are more complicated than simple considerations of 
conserved residues and hydrogen bonding.  While CGG-R7-8, CTGA-R7-1, T7(T3), 
T7(K1F), and T7(N4) are all potentially able to form energetically favorable interactions 
with their respective cognate promoters, it seems likely that their specificity loops are not 
oriented properly to allow for such potential interaction to occur.  Unpredictable 
mutations in regions several angstroms away were needed to unlock the latent promoter 
specificity.   
In addition to the utility of directed evolution in general, the utility of CPR 
specifically is evident.  As noted previously, there have been many attempts by several 
labs to evolve or engineer active and orthogonal T7 RNA polymerase promoter 
specificity variants.  Their respective attempts relied on different methods, but all seemed 
to produce proteins with low activity and specificity.  This is likely due to the problems 
of thresholding effects, fitness effects, and the lack of control over the parameters.  CPR 
allows for selective enrichment over a range of activities, is largely uncoupled from host 
fitness, and allows the user to control the mutation rate as well as the specific regions that 
are allowed to evolve.  
The large dynamic range of CPR is of critical importance to the success of the 
selections for promoter specificity.  In order to make a polymerase based on wild type T7 
RNA polymerase that is orthogonal to PT7, one must choose a promoter that is divergent 
enough from PT7 to limit the chance of a generalist strategy being sufficient to survive the 
selection.  This is depicted as two curves with minimal overlap in Figure 3-36.  Several 
mutations are likely required to “jump” from one “fitness mountain” to the next (dashed 
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arrow (1) in Figure 3-36).   This was evident in the early rounds of the selections for the 
use of PCTGA, as the library converged on a single variant, CTGA-R7-1 (out of an initial 
6.4 x 107) even though that variant was only about 1% active.  This suggests that the 
large initial jump to a different “fitness mountain” is difficult, resulting in a jump from 
the peak of one mountain to a lower level on the other mountain (the jump from wild type 
T7 RNA polymerase to CTGA-R7-1 in Figure 3-36).  The direct jump from peak to peak 
can only be achieved if all the mutations required for maximal activity on the new peak 
are present in the library.  Fortunately, CPR’s ability to select at the lower levels of 
activity allowed for a “foothold” (i.e. CTGA-R7-1) to be established on the new 
mountain.   CPR’s ability to select at the higher ends of activity was equally important, as 
CTGA-R7-1 was able to mature into CTGA-R13-AKSIRV because highly active variants 
were able to outcompete moderately active variants (dashed arrow (2) in Figure 3-36).  
In the end, a selection that favors the most active variant in a population is essential to the 
evolution of new specificity.   
 
Figure 3-36.  Selective pressure and the evolution of enzyme specificity. 
In the evolution of a new enzyme specificity, an initial jump must be made from one 
specificity to the other (dashed arrow (1)).  Strong selective pressure is then required to 
push the enzyme to the new peak (dashed arrow (2))  
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MATERIALS AND METHODS 
Library design and selection 
For the selection of an RNA polymerase mutant capable of recognizing PT7, PCGG, 
and PCTGA, site saturation mutagenesis was used to randomize the residues R746, L747, 
N748, R756, L757, and Q758 of the T7 RNA polymerase promoter specificity loop.  
Diversity was introduced into the oligonucleotides during synthesis by the use of 
degenerate trimer phosphoramidites (Glen Research).  This degenerate oligonucleotide 
was amplified by PCR, yielding a short double stranded library of the promoter 
specificity loop and short flanking regions.  This short region was used in an overlap PCR 
with 5′ and 3′ pieces of the T7 RNA polymerase ORF.  The resulting full-length T7 RNA 
polymerase library was digested and ligated into the pQE-RSS backbone (in which a 
strong T5-lac promoter drives T7 RNA polymerase).    
The Taq DNA polymerase gene was cloned into a modified pACYC-duet 
(Novagen) backbone with a single T7 promoter; this construct was named pACYC-Taq.  
Variants of this plasmid with synthetic promoters drive Taq DNA polymerase were 
generated using Mega-primer PCR (Bryksin and Matsumura, 2010) or Isothermal 
assembly (Gibson, 2011).  BL21 gold cells (Agilent) were transformed with pACYC-Taq 
(or its derivative with altered promoter) and grown overnight.  250 μl of this culture was 
subcultured into 20 ml 2xYT growth medium and grown at 37 °C for two hours (reaching 
an OD600 of approximately 0.5).  The culture was then centrifuged at 4000 g at 4 °C and 
washed with ice cold 10% glycerol four times, with the fourth resuspension in 100 μl of 
10% glycerol.  This cell slurry (~200 μl total) was combined with 2 μl (~50 ng) purified 
ligation and electroporated using 0.2 cm cuvettes at 2.5 kV in an E. coli pulser (BioRad).  
This routinely resulted in roughly 107 CFUs (multiple replicates were pooled for early 
rounds in order to attain full coverage).   
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100 μl overnight transformation cultures were subcultured in 2 ml 2xYT medium, 
grown for one hour (OD600 ~0.6) and induced with 0.05 mM IPTG at 37 °C for four 
hours.  200 μl of the induced culture was centrifuged at 5,000 g for 10 minutes to pellet 
the cells.  The supernatant was removed and cells were gently resuspended in 20 μl 10x 
PCR buffer (500 mM KCl, 100 mM Tris-HCl pH 8.3, 15 mM MgCl2) 10 μl dNTP mix (4 
mM each), 4 μl each primer (20 μM), and 162 μl water.  Emulsification was performed 
by slowly adding resuspended cells to 600 μl of spinning oil mix (438 μl Tegosoft DEC 
(Evonik), 42 μl AbilWE09 (Evonik), and 120 μl Mineral oil (Sigma)).  The oil mixture 
was constantly spun in a tube (Sarstedt 13 ml 95 mm x 16.8 mm) on ice using a stirbar 
(Spinplus 9.5 mm x 9.5 mm Teflon, Bel-Art) on a magnetic plate (Corning) at the 
maximum setting (1150 rpm).  The cell mixture was slowly added over a one minute 
interval and spun for an additional four minutes.  The emulsified cells were thermal 
cycled (95 °C:3 min, 20 cycles [95 °C:30 sec, 55 °C:30 sec, 72 °C:2 min/kb], 72 °C:5 
min) such that cells containing the most active enzymes will also contain the most Taq 
DNA polymerase and will preferentially PCR amplify.  The emulsion was broken in two 
steps.  Firstly, it was centrifuged at 10,000 g for five minutes and the oil (upper) phase 
was removed.  Secondly, 300 μl of bead buffer (0.2 M NaCl, 10 mM Tris-HCl (pH 7.4), 
1 mM EDTA, 0.1% Tween-20) and 500 μl chloroform was added and the mixture was 
vortexed vigorously.  The mixture was transferred to a heavy-gel phase-lock tube (5 
Prime) and upon centrifugation at 16,000 g for two minutes the aqueous (upper) phase 
was collected along with any nucleic acids present.  To facilitate purification of the DNA 
PCR amplified by Taq DNA polymerase from the template plasmid DNA, primers with 
5′ biotin groups were used in the emulsion PCR step.  Biotinylated PCR products were 
purified using streptavidin coated beads (MyOne Streptavidin C1 Dynabeads, Life 
Technologies) and used as a template for re-amplification using nested primers.  This 
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PCR product was gel purified and used in an assembly PCR, thus regenerating the full-
length T7 RNA polymerase ORF.  This was followed by digestion and ligation into the 
pQE-RSS backbone. 
In Rounds 8 to 12 of the PCGG selection, Rounds 8 to 13 of the PCTGA selection, 
and all rounds of the PT3, PK1F, and PN4 selections, a larger region (amino acids 633 to 
793) of the polymerase coding sequence was reamplified (and thus allowed to evolve).  
In these rounds, pQE-RSS was replaced by pLUV-RSS in which the strong T5 promoter 
was replaced with the moderate-strength promoter, lacUV5 promoter.   
Error-prone PCR was performed on the larger region prior to PCGG Rounds 8, 11, 
13, 15, and 16, PCTGA Rounds 8, 10, 11, and 13, as well as before PT3, PK1F, and PN4 
Rounds 1, 3 and 5.   Briefly the reaction mixture was composed of 50 mM KCl, 10 mM 
Tris-HCl pH 8.3, 2.5 mM MgCl2, 5 μg/ml BSA, 0.35 mM dATP, 0.4 mM dCTP, 0.2 mM 
dGTP, 1.35 mM dTTP, 0.5 mM MnCl2, 0.5 μM each primer, 2 ng/μl template, and 0.8 
U/μl Taq DNA polymerase (New England Biolabs) and was thermal cycled (95 °C:4 min, 
25 cycles [95 °C:30 sec, 55 °C:30 sec, 72 °C:2 min], 72 °C:5 min).   This achieved the 
expected one mutation per 500 base pairs. 
In vivo GFP assay 
Purified plasmid of T7 RNA polymerase mutants (or ligations from rounds of 
selection) were electroporated into BL21-gold cells containing pACYC derivatives in 
which T7 promoter variants drive GFP production.  Transformations (or single colonies) 
were grown at 37 °C overnight.  100 μl of the culture was grown in 2 ml 2xYT medium 
at 37 °C for one hour (OD600 ~0.6) and induced with 0.05 mM IPTG for four hours.  
This concentration of IPTG was chosen in order to limit metabolic overload on the host 
and prevent saturation of signal.  After induction, cells were measured for OD600 on a 
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Synergy-HT plate reader (Bio-Tek) and GFP fluorescence (Excitation/ Emission 481 
nm/507 nm) on a Safire monochromator (Tecan).  Images of T7 RNA polymerase-driven 
GFP expression spinning down 2 ml of induced culture, decanting the supernatant, and 
resuspending cells in 500 μl PBS.  The resuspended cells were excited with a 
transilluminator (475 nm Excitation) and visualized with a FluorChem Q (Cy3-filter, 
Protein Simple). 
In vivo RNA polymerase cross-reactivity assays 
A promiscuous mutant of the phenylalanine aminoacyl-tRNA synthetase, PheS 
A294G (Kast and Hennecke, 1991; Thyer et al., 2013), was cloned in place of the Taq 
DNAP open reading frame in pACYC-Taq.  Purified plasmid of T7 RNA polymerase 
mutants were electroporated into BL21-gold cells containing pACYC-PheS with PheS 
A294G driven by the wild type T7 promoter.  Transformations were grown at 37 °C 
overnight.  100 μl of the culture was grown in 2 ml 2xYT medium at 37 °C for one hour 
(OD600 ~0.6) and induced at 0.05 mM IPTG for four hours.  Cells were diluted with 
media (containing the same antibiotics and IPTG as the growth media) to OD600s of 0.1, 
0.01, and 0.001.  5 μl of each dilution was plated on 0 mM, 5 mM, 10 mM, 15 mM, or 20 
mM 4-chloro-DL-phenylalanine (Cl-Phe; Sigma).  The plating media also contained 
0.4% glycerol, 0.5% yeast extract, 1% NaCl, 1.5% agar, 50 μg/ ml kanamycin, 24 μg/ ml 
chloramphenicol, and 0.05 mM IPTG.  Plates were grown at 37 °C for 20 hours and 
visualized with ambient white light on a FluorChem Q (Protein Simple).  Mutant cross-
reactivity may be judged be the dose dependent cytotoxicity of Cl-Phe, which is only 
lethal (at the concentrations used) when PheS A294G is expressed. 
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T7 RNA polymerase purification 
For in vitro transcription assays, T7 RNA polymerase variants were purified by 
standard Ni-NTA 6xHis (N-terminal) methods.  The plasmid pQE-T7RSS (or a derivative 
thereof for T7 RNA polymerase mutants) was transformed in BL21-gold (Agilent).  Cells 
were grown in 2xYT media at 37 °C until an OD600 ~0.7-0.8 was reached.  Cells were 
induced for four hours with 1 mM IPTG, pelleted, and frozen at -80 °C. Pellets were 
resuspended in binding buffer (50 mM Tris-HCl, pH 8.0, 0.5 M NaCl, 5 mM imidazole). 
Resuspended cells were lysed via sonication on ice using 50% probe amplitude for three 
minutes (1 sec ON, 1 sec OFF). Cell debris was pelleted by centrifugation at 10,000 g for 
30 minutes. His-tagged T7 RNA polymerase was purified by immobilized metal affinity 
chromatography (IMAC). The lysate was run over 1 ml (bead volume) Ni-NTA gravity 
column pre-equilibrated with binding buffer. The column was washed with 10x column 
volumes of wash buffer (50 mM Tris-HCl, pH 8.0, 0.5 M NaCl, 20 mM imidazole). T7 
RNA polymerase was eluted off the column by the addition of 4x column volumes of 
elution buffer (50 mM Tris-HCl, pH 8.0, 0.5 M NaCl, 250 mM imidazole).  Eluates were 
dialyzed twice against a storage buffer (50 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM 
DDT, 1 mM EDTA).  Concentrations were adjusted to 1 mg/ml and added to an equal 
volume of glycerol (final concentration 0.5 mg/ml). 
In vitro transcription assay 
Transcription templates were designed such that a T7 promoter variant was 
immediately upstream of the fluorescent aptamer Spinach.  Templates were prepared by 
PCR and agarose gel purification using QIAquick Gel Extraction Kit (Qiagen).  
Transcription reactions were assembled by combining 40 mM Tris-HCl pH 7.0, 30 mM 
MgCl2, 6 mM spermidine, 6 mM each NTP, 10 mM DTT, and 0.17 mg/ml DFHBI (Paige 
et al., 2011) with 0.5 μM of the appropriate T7 RNA polymerase and 0.5 μM of the 
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appropriate DNA template.  Reactions were incubated for up to four hours at 37 °C with 
Spinach fluorescence (Excitation/ Emission 469 nm/501 nm) reading taken every one to 
three minutes in a Safire monochromator (Tecan).   
REFERENCES  
Bryksin, A. V, and Matsumura, I. 2010. Overlap extension PCR cloning: a simple and 
reliable way to create recombinant plasmids. BioTechniques 48:463–5. 
Cheetham, G. M., Jeruzalmi, D., and Steitz, T. A. 1999. Structural basis for initiation of 
transcription from an RNA polymerase-promoter complex. Nature 399:80–3. 
Chelliserrykattil, J., Cai, G., and Ellington, A. D. 2001. A combined in vitro/in vivo 
selection for polymerases with novel promoter specificities. BMC Biotechnology 
1:13. 
Davidson, E. A., Meyer, A. J., Ellefson, J. W., Levy, M., and Ellington, A. D. 2012. An 
in vitro Autogene. ACS Synthetic Biology 1:190–196. 
Dickinson, B. C., Leconte, A. M., Allen, B., Esvelt, K. M., and Liu, D. R. 2013. 
Experimental interrogation of the path dependence and stochasticity of protein 
evolution using phage-assisted continuous evolution. Proceedings of the National 
Academy of Sciences of the United States of America. 
Ellefson, J. W., Meyer, A. J., Hughes, R. A., Cannon, J. R., Brodbelt, J. S., and Ellington, 
A. D. 2014. Directed evolution of genetic parts and circuits by compartmentalized 
partnered replication. Nature Biotechnology 32:97–101. 
Esvelt, K. M., Carlson, J. C., and Liu, D. R. 2011. A system for the continuous directed 
evolution of biomolecules. Nature 472:499–503. 
Franco, E., Friedrichs, E., Kim, J., Jungmann, R., Murray, R., Winfree, E., and Simmel, 
F. C. 2011. Timing molecular motion and production with a synthetic transcriptional 
clock. Proceedings of the National Academy of Sciences of the United States of 
America 108:E784–93. 
Gibson, D. G. 2011. Enzymatic assembly of overlapping DNA fragments. Methods in 
Enzymology 498:349–61. 
Ikeda, R. A., Ligman, C. M., and Warshamana, S. 1992. T7 promoter contacts essential 
for promoter activity in vivo. Nucleic Acids Research 20:2517–24. 
 105 
Imburgio, D., Rong, M., Ma, K., and McAllister, W. T. 2000. Studies of promoter 
recognition and start site selection by T7 RNA polymerase using a comprehensive 
collection of promoter variants. Biochemistry 39:10419–30. 
Kast, P., and Hennecke, H. 1991. Amino acid substrate specificity of Escherichia coli 
phenylalanyl-tRNA synthetase altered by distinct mutations. Journal of Molecular 
Biology 222:99–124. 
Khersonsky, O., and Tawfik, D. S. 2010. Enzyme promiscuity: a mechanistic and 
evolutionary perspective. Annual Review of Biochemistry 79:471–505. 
Kim, J., White, K. S., and Winfree, E. 2006. Construction of an in vitro bistable circuit 
from synthetic transcriptional switches. Molecular Systems Biology 2:68. 
Kim, J., and Winfree, E. 2011. Synthetic in vitro transcriptional oscillators. Molecular 
Systems Biology 7:465. 
Matsumura, I., and Ellington, A. D. 2001. In vitro evolution of beta-glucuronidase into a 
beta-galactosidase proceeds through non-specific intermediates. Journal of 
Molecular Biology 305:331–9. 
Paige, J. S., Wu, K. Y., and Jaffrey, S. R. 2011. RNA Mimics of Green Fluorescent 
Protein. Science 333:642–646. 
Raskin, C. A., Diaz, G. A., and McAllister, W. T. 1993. T7 RNA polymerase mutants 
with altered promoter specificities. Proceedings of the National Academy of 
Sciences of the United States of America 90:3147–51. 
Rong, M., He, B., McAllister, W. T., and Durbin, R. K. 1998. Promoter specificity 
determinants of T7 RNA polymerase. Proceedings of the National Academy of 
Sciences of the United States of America 95:515–9. 
Shis, D. L., and Bennett, M. R. 2013. Library of synthetic transcriptional AND gates built 
with split T7 RNA polymerase mutants. Proceedings of the National Academy of 
Sciences of the United States of America. 
Subsoontorn, P., Kim, J., and Winfree, E. 2012. Ensemble Bayesian analysis of 
bistability in a synthetic transcriptional switch. ACS Synthetic Biology 1:299–316. 
Temme, K., Hill, R., Segall-Shapiro, T. H., Moser, F., and Voigt, C. A. 2012a. Modular 
control of multiple pathways using engineered orthogonal T7 polymerases. Nucleic 
Acids Research 40:8773–81. 
 106 
Temme, K., Zhao, D., and Voigt, C. A. 2012b. Refactoring the nitrogen fixation gene 
cluster from Klebsiella oxytoca. Proceedings of the National Academy of Sciences of 
the United States of America 109:7085–90. 
Thyer, R., Filipovska, A., and Rackham, O. 2013. Engineered rRNA Enhances the 
Efficiency of Selenocysteine Incorporation during Translation. Journal of the 
American Chemical Society. 
Tokuriki, N., Jackson, C. J., Afriat-Jurnou, L., Wyganowski, K. T., Tang, R., and Tawfik, 
D. S. 2012. Diminishing returns and tradeoffs constrain the laboratory optimization 
of an enzyme. Nature Communications 3:1257. 
Wang, H. H., Kim, H., Cong, L., Jeong, J., Bang, D., and Church, G. M. 2012. Genome-
scale promoter engineering by coselection MAGE. Nature Methods 9:591–3. 
 
  
 107 
Chapter 4:  Stabilization of T7 RNA polymerase substrate specificity 
mutants 
On average, mutations are deleterious to proteins.  Mutations conferring new 
function to a protein often come at the expense of protein folding or stability, reducing 
overall activity (Wang et al., 2002; Tokuriki et al., 2008; Romero and Arnold, 2009; 
Levin et al., 2009; Soskine and Tawfik, 2010).   
To date, several T7 RNA polymerase variants have been designed or evolved to 
accept and incorporate nucleotides with modified ribose moieties.  These modified RNAs 
have proven useful, especially in vivo, but the transcriptional yields are typically lower 
than with native RNA, possibly due to the instability of the polymerase mutants.  Here it 
is demonstrated that mutations previously shown to increase the thermal tolerance of T7 
RNA polymerase can increase the activity of mutants with expanded substrate 
preferences.  The resulting polymerase mutants can be employed to generate 2′-O-methyl 
modified RNA with greater yields than is achieved with enzymes currently employed.   
INTRODUCTION 
Background and rationale 
The need for RNA polymerases capable of transcribing RNAs with 2′-modified ribose 
moieties 
RNA is a versatile and useful macromolecule, but its chemical instability can 
render it unsuitable for many therapeutic and biotechnology applications.  
Oligonucleotides with altered chemistry, especially those with modifications at the 2′ 
position of the (deoxy)ribose have proven to be of great value (Wilson and Keefe, 2006).  
As antisense probes, 2′-O-methyl RNA has higher Tm values, faster binding, and greater 
stability than natural RNA (Majlessi et al., 1998).  siRNA possessing 2′-F and 2′-O-
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methyl RNA have also proven to be more stable and target-specific (Layzer, 2004; 
Kraynack and Baker, 2006; Jackson et al., 2006).  Additionally, in vitro selections with 
2′-modified NTPs have yielded aptamers and ribozymes with greater stability and 
enhanced chemical potential (Beaudry et al., 2000; Lupold et al., 2002; Healy et al., 
2004; Burmeister et al., 2005; Keefe and Cload, 2008; Waters et al., 2011).  
While modified RNA can be chemically synthesized it is often preferable to 
enzymatically produce it.  This is especially important for in vitro selection, which relies 
on cycles of transcription, reverse transcription, and PCR (Ellington and Szostak, 1990; 
Tuerk and Gold, 1990; Knudsen et al., 2002). T7 RNA polymerase has long been utilized 
for the production of RNA in vitro, and has previously been the subject of engineering 
and evolution efforts to expand its substrate range.   
T7 RNA polymerase substrate specificity mutants 
The engineering and evolution of T7 RNA polymerase substrate specificity 
mutants is described in greater detail in Chapter 1.  The properties of the mutants 
developed by those methods are now discussed.  The name, sequence, substrate range, 
and source of these mutants are summarized in Table 4-1. 
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Table 4-1.  T7 RNA polymerase nucleotide specificity mutants. 
The commercially important Y639F mutant allows for the polymerization of RNA 
transcripts containing dNTPs as well as nucleotides with 2′-fluoro and 2′-amino modified 
ribose (Kostyuk et al., 1995; Sousa and Padilla, 1995; Huang et al., 1997).   
 The Y639F, H784A double mutant ("FA") can incorporate nucleotides with 
bulky modifications at the 2′ position (e.g. 2′-O-methyl and 2′-azido) (Brieba and Sousa, 
2000; Padilla and Sousa, 2002).   
An evolved mutant, termed "RGVG," (E593G, Y639V, V685A, H784G) showed 
at least as much activity as FA in transcriptions containing three NTPs and either 2′-O- 
methyluridine (rVmU), 2′-O-methylcytidine (rDmC), or 2′-O-methyladenosine (rBmA).  
In addition, it was uniquely able to make transcripts containing two or three 2′-O-methyl 
NTPs (rRmY and rGmH), however with reduced transcription yields (Chelliserrykattil 
and Ellington, 2004). 
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Another evolved mutant, "VRS," (G542V, H772R, H784S) was reported to 
incorporate 2′-fluoropyrimidines (Chelliserrykattil and Ellington, 2004).   
The “2P16” mutant (I119V, G225S, K333N, D366N, F400L, E593G, Y639V, 
S661G, V685A, H784G, F880Y) is a mutant of RGVG with seven additional mutations.  
It was reported to have similar activity with 2′-O-methyluridine (rVmU) and enhanced 
activity with 2′-Se-methyluridine (Siegmund et al., 2012).   
The R425C mutant is reported to enable the synthesis of 1000-nucleotide long 
mRNA composed entirely of 2′-O-methylnucleotides (mN) (Ibach et al., 2013). 
Activity stability trade-offs in enzyme mutants 
While the catalytic properties of these enzymes make them useful tools, several of 
them suffer from low activity, even with normal ribonucleotides.  It has been proposed 
that mutations that confer new activity to an enzyme also destabilize the protein, 
rendering it less active overall (Wang et al., 2002; Tokuriki et al., 2008; Romero and 
Arnold, 2009; Levin et al., 2009; Soskine and Tawfik, 2010).  For example, two 
mutations in TEM1 β-lactamase (E104K, R164S) can alter substrate specificity to 
ceftazidime (CAZ) over its natural substrate 6-furylacrylpenicillanic acid (FAP) (Figure 
4-1).  However, the overall activity of this double mutant is low, and its Tm is reduced 
compared to wild type TEM1.  Interestingly, the M182T mutation has no effect on 
substrate preference, but increases the Tm of wild type TEM1 as well as the E104K, 
R164S double mutant.  This triple mutant (E104K, R164S, M182T) is approximately 
twice as active as the double mutant.  One possible interpretation of these data is that the 
E104K and R164S mutations confer the new activity (use of CAZ), but these mutations 
also push the enzyme below a stability threshold, thus lowering its activity.  As the 
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M182T mutant is more stable than wild type TEM1, it can tolerate the destabilizing 
effects of the E104K and R164S mutations.   
 
Figure 4-1.  Activty stability trade-offs in TEM1 β-lactamase. 
Top) The kcat with two substrates and the Tm of four TEM1 mutants are shown.  Bottom 
left) The structures of the two substrates are shown.  Bottom right) The E104K, R164S 
(KS) mutant is below a stability threshold (dotted line). M182T (T) is more stable than 
wild type TEM1 (WT), so mutation from WT to M182T to E104K, R164S, M182T is a 
feasible pathway to a new activity (arrows).  This figure is based on data from a study of 
TEM1 β-lactamase (Wang et al., 2002), and includes the structures depicted therein. 
In this chapter, this idea is put to the test, as suspected stabilizing mutations are 
added to the T7 RNA polymerase mutants described above.  It will be seen that T7 RNA 
polymerase mutants with altered substrate specificity and low activity can benefit from 
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stabilizing mutations, which increase overall activity without affecting substrate 
preference. 
RESULTS AND DISCUSSION 
Analysis of the effects of stabilizing mutations on the activity of theT7 RNA 
polymerase substrate specificity mutant G542V, H784S  
The Ellington Lab’s previous selection for RNA polymerases with altered 
substrate specificity (Chelliserrykattil and Ellington, 2004) focused on the four amino 
acids that are proximal to the incoming nucleotide, (R425, G542, Y639, and H784), and 
thus likely played a role in substrate recognition (Cheetham and Steitz, 1999; Temiakov 
et al., 2004).  One of the resulting mutants, designated “VRS,” could incorporate 2′-F-
modified pyrimidines.  VRS had mutations at two of the randomized residues (i.e. G542V 
and H784S).  Interestingly, the H772R mutation of VRS arose during the selection 
despite H772 not being one of the randomized residues.  Data alluded to in the initial 
publication (but not shown) suggest that H772R was not important.   
It was decided to investigate the G542V, H784S double mutant (“VS”) as an 
alternative to Y639F for the generation of 2′-F-modified RNA.  The enzyme was purified 
and tested for its ability to polymerize RNA composed of either natural NTPs (rN) or 
ribopurines and 2′-F-pyrimidines (rRfY).  Unexpectedly, the enzyme was found to be 
almost completely inactive.   
In order to understand the reason for the inactivity of the VS variant and the 
potential role of the H772R mutation, VRS was cloned, purified and tested.  Real-time 
polymerase activity was assayed using the fluorescent aptamer Spinach (Paige et al., 
2011) (Figure 4-2), which was found to fluoresce as a purely ribo-aptamer and when 
substituted with 2′-F-pyrimidines, although fluorescence per molecule is about 3-fold 
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lower in the rRfY form.  It can be seen that both VRS and VS are more tolerant of 2′-F-
pyrimidines than wild type T7 RNA polymerase.  It is also evident that VRS is more 
active than VS in transcriptions using NTPs as well as 2′-F-pyrimidines.   
 
Figure 4-2.  The effects of the H772R mutation on the activity of the VRS mutant.  
Left) Real time measurement of Spinach fluorescence (in Relative Fluorescence Units) 
from ribonucleotide (rN) transcription. Right) Real time measurement of Spinach 
fluorescence (in Relative Fluorescence Units) from 2′-F-pyrimidine (rRfY) transcription.  
All readings are normalized to the output of wild type T7 RNA polymerase (WT) at 30 
minutes defined as 100; numbers are not comparable between graphs.   
Since VS showed a decrease in activity for each substrate composition, it was 
hypothesized that H772R contributes to the overall activity of VRS, apart from any 
substrate preference considerations.  H772R is not near the substrate recognition domain, 
but it has been observed in other published selections for T7 RNA polymerase activity 
(Ellefson et al., 2014; Dickinson et al., 2013) and several of the selections detailed in 
Chapter 3.  This suggests that H772R may be a general stabilizer, and that it would 
increase the overall activity of the (possibly unstable) G542V, H784S variant.  Several 
derivatives of VRS with suspected stabilizing or enhancing mutations were cloned, 
purified, and tested (Table 4-2).   
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Table 4-2.  Potential stabilization mutants of the T7 RNA polymerase nucleotide 
specificity mutant, VRS. 
The list of potentially stabilizing mutations includes V625L and V783I which 
were suspected to confer stability to T7 RNA polymerase.  Briefly, the Havranek Lab 
provided a list of mutations predicted by the Rosetta software to allow tighter packing of 
the T7 RNA polymerase hydrophobic core.  Single mutants of the 10 highest scoring 
mutations were made and tested in vivo.  Two mutations that abolished activity were 
eliminated from consideration.  Several combinations of the remaining eight mutations 
were made and then gene shuffled together.  Two rounds of selection by 
compartmentalized partnered replication (CPR) were then performed.  Three mutations 
A288V, V625L, and V783I occurred in more than half of the resulting mutants.  
Concurrently, wild type T7 RNA polymerase was subjected to error-prone PCR and 
several rounds of selection by CPR.  20 total clones were sequenced after Rounds 3 and 
4, revealing T7 RNA polymerase mutants with between two and 10 mutations each.  Two 
mutants contained V625L and one contained V783I.  The possibility that these two 
mutations may confer stability to VRS was therefore considered. 
 115 
The P266L mutation was included because it has been shown to facilitate promote 
clearance (Guillerez et al., 2005).  It has also anecdotally been associated with enhanced 
incorporation of unnatural nucleotides.   
The so-called “M5” (S430P, N433T, S633P, F849I, and F880Y) sets of mutations 
was considered based on patent literature suggesting that it confers thermal stability to T7 
RNA polymerase (Liao et al., 2003; Sugiyama et al., 2009).  “M6” (P266L, S430P, 
N433T, S633P, F849I, and F880Y) combines the M5 mutations with P266L.   F880Y 
was considered independently of the M5 mutations because it seemed to enhance the 
autogene selections (Davidson et al., 2012)(Chapter 2). 
The mutants listed in Table 4-2 were cloned, expressed, purified and used for in 
vitro transcription of the Spinach aptamer.  The in vitro transcription reactions contained 
either all four NTPs (rN) or ribopurines and 2′-F-pyrimidines (rRfY) (Figure 4-3).  The 
M5 and M6 mutations increase the activity of the VRS parent in each case.   
 
Figure 4-3.  The effects of stabilizing mutations on the activity of the VRS mutant. 
Left) Measurement of ribonucleotide (rN) transcriptional output. Right) Measurement of 
2′-F-pyrimidine (rRfY) transcriptional output.  Real time readings of Spinach 
fluorescence (in Relative Fluorescence Units) were taken; the readings at three hours are 
shown.  All readings are normalized to wild type T7 RNA polymerase (WT) defined as 
100; numbers are not comparable between graphs.  Error bars represent standard error 
resulting from three independently assembled reactions.   
 116 
The “M5” mutations have only been described in patent literature.  Patent claims 
suggest that the mutations arose in a T7 RNA polymerase selection for transcriptional 
activity at higher temperatures, described in Chapter 1.  A random mutagenesis library 
of T7 RNA polymerase mutants was tasked with driving chloramphenicol 
acetyltransferase expression in Geobacillus stearothermophilus at 45 °C to 50 °C.  
Surviving hosts had their T7 RNA polymerase expression plasmids sequenced.  The 
mutation S633P was described first (Liao et al., 2003), followed by the mutations S430P, 
F849I, and F880Y (Sugiyama et al., 2009).  The quadruple mutant combining those 
mutations is reported to have an increased half-life at 50 °C and increased transcription at 
that temperature.  The primers reportedly used to generate this “quadruple” mutant confer 
an additional N433T mutation.  It is unclear if the patent holders meant to include this, as 
it is not discussed.  Regardless, the “M5” (S430P, N433T, S633P, F849I, and F880Y) 
mutations increased the activity of VRS with the rN and rRfY formulations, as did the 
“M6” mutations, which includes the P266L mutation on top of the M5 mutations.  The 
M5 are M6 mutations are potentially effective stabilizers and could be used to increase 
the activity of the substrate specificity mutants listed in Table 4-1.   
Analysis of the effects of the M5 mutations on the activity of T7 RNA polymerase 
substrate specificity mutants 
The Yin Lab has previously solved the crystal structure of the transcribing M5 T7 
RNA polymerase mutant in the initiation complex (unpublished work).  Interestingly, 
there are few gross morphological differences to the comparable wild type T7 RNA 
polymerase crystal (Cheetham and Steitz, 1999) (Figure 4-4).  There is, however, an 
added hydrogen bond made by F880Y, which may stabilize the two halves of the palm 
domain.  It should be noted that the F880Y mutation is not sufficient to increase VRS 
activity (see VRSY in Figure 4-3).  It should also be noted that T7 RNA polymerase 
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undergoes two major conformational changes.  It is therefore possible that the M5 
mutations cause large structural changes in one of the other conformations. 
 
Figure 4-4.  Structure of the transcribing “M5” RNA polymerase initiation complex. 
The M5 T7 RNA polymerase (white) overlayed with wild type T7 RNA polymerase 
(dark gray, PDB accession number 1QLN (Cheetham and Steitz, 1999).  Amino acid 
changes are shown in magenta, DNA in blue, RNA in red.  The B-factor, a measure of 
how ordered a region is, is shown.  Inset) The added hydroxyl group resulting from the 
F880Y mutation (cyan) forms a hydrogen bond (yellow dashed line) with the peptide 
backbone between P474 and F475.   
To determine whether the M5 and M6 mutations could increase the activity of 
other T7 RNA polymerase mutants, they were added to several “parental” mutants.  
Several polymerases with varying specificity for different ribose moieties, namely wild 
type T7 RNA polymerase (WT), Y639F, FA, RGVG, VRS, and R425C (Table 4-1 and 
4-3) were cloned with and without the P266L mutation.  Each of these 12 “parental” 
mutants was then mutated to contain the M5 mutations (the combination of M5 and 
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P266L forms M6).  For comparison, a recently described mutant, 2P16, which is likely a 
stabilized version of RGVG, was also included.  These 25 polymerases were purified and 
assayed for transcriptional activity with canonical NTPs in vitro (Table 4-3, Figure 4-5).  
The M5 mutations increase the transcriptional activity of each parental polymerase.  
 
Table 4-3.  T7 RNA polymerase nucleotide specificity mutants with M5 mutations. 
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Figure 4-5.  The effects of the M5 mutations on the ability of T7 RNA polymerase 
specificity mutants to transcribe canonical NTPs. 
Measurement of ribonucleotide (rN) transcriptional output. Real time readings of Spinach 
fluorescence (in Relative Fluorescence Units) were taken; the readings at one hour are 
shown.  All readings are normalized to wild type T7 RNA polymerase (WT) defined as 
100.  Error bars represent standard error resulting from three independently assembled 
reactions.   
To assess whether the addition of the M5 mutations affected the substrate 
recognition characteristics of the substrate activity mutants,  each mutant was assayed for 
transcriptional activity with ribopurines and 2′-F-pyrimidines.  Interestingly, wild type T7 
RNA polymerase and the Y639F mutant did not benefit from M5 mutations in this 
context.  In contrast, the FA, FA-L, VRS, RGVG, and RGVG-L variants all saw an 
increase in activity upon addition of the M5 mutations.  These results suggest that the M5 
mutations can increase activity, without altering specificity.   
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Figure 4-6.  The effects of the M5 mutations on the ability of T7 RNA polymerase 
specificity mutants to transcribe 2′-F-pyrimidines. 
Measurement of 2′-F-pyrimidine (rRfY) transcriptional output.  Real time readings of 
Spinach fluorescence (in Relative Fluorescence Units) were taken; the readings at two 
hours are shown.  All readings are normalized to wild type T7 RNA polymerase (WT) 
defined as 100.  Error bars represent standard error resulting from three independently 
assembled reactions.   
Analysis of the effects of the M5 and M6 mutations on the incorporation of 2′-O-
methyl NTPs 
While the activities of several mutants in an rRfY context were improved by the 
M5 mutations, none matched the activity of Y639F, which is the standard T7 RNA 
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polymerase variant used to incorporate 2′-F-pyrimidines and was not improved by the M5 
mutations.  Additionally, the mutants most improved by the M5 mutations (FA and 
RGVG) are most known for their ability to incorporate 2′-O-methylnucleotides.  
Nucleotide formulations containing 2′-O-methylnucleotides were therefore focused upon.   
Each enzyme was assayed for its ability to transcribe 2′-O-methyluridine along 
with ATP, CTP, and GTP (Figure 4-7).  As before, FA, FA-L, RGVG, and RGVG-L all 
saw increases in activity when the M5 mutations were included.  The VRS family of 
enzymes showed no activity in the rVmU context, consistent with previously reports 
(Chelliserrykattil and Ellington, 2004).  Interestingly, transcript from the mutants based 
on R425C could not be detected, in marked contrast to previously published results 
(Ibach et al., 2013).  2P16 is more active than RGVG as previously claimed (Siegmund et 
al., 2012), but is not as active as either RGVG-M5 or RGVG-M6.   
 
Figure 4-7.  The effects of the M5 mutations on the ability of T7 RNA polymerase 
specificity mutants to transcribe 2′-O-methyluridine.  
Transcription assay for the incorporation of 2′-O-methyluridine (rVmU).  Transcripts 
were labelled by inclusion of [α32P]ATP and analyzed by denaturing PAGE.  A reaction 
of wild type T7 RNA polymerase (WT) with ribonucleotides (rN) is included for 
comparison.  Transcriptions ran for four hours, two distinct gels are shown. 
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Based on the above results, further assays were limited to a subset of the most 
active polymerases and those that serve as suitable comparisons. This subset was re-
assayed for the ability to incorporate 2′-O-methyluridine (rVmU); running samples on a 
single gel to allow for quantitative comparison (Figure 4-8).  This was followed by a 
similar assay for the incorporation of 2′-O-methylpyrimidines (rRmY, Figure 4-9), and 
2′-O-methyladenosine and 2′-O-methylpyrimidines (rGmH) (Figure 4-10).  As before, 
the M5 mutations enhanced the activity of the FA and RGVG enzymes for each set of 
substrates.  RGVG-M6 was the most active enzyme in all conditions, yielding at least 25-
fold more RNA than the FA mutant, which is the most commonly used enzyme for 
generating 2′-O-methyl RNA.   
 
Figure 4-8.  Quantitative comparison of T7 RNA polymerase specificity mutants’ 
incorporation of 2′-O-methyluridine. 
Transcription assay for the incorporation of 2′-O-methyluridine (rVmU).  Transcripts 
were labelled by inclusion of [α32P]ATP and analyzed by denaturing PAGE.  All values 
are normalized to 100, representing the yield of wild type T7 RNA polymerase with 
ribonucleotides (rN).  Transcriptions ran for four hours. 
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Figure 4-9.  Quantitative comparison of T7 RNA polymerase specificity mutants’ 
incorporation of 2′-O-methylpyrimidines. 
Transcription assay for the incorporation of 2′-O-methylpyrimidines (rRmY).  Transcripts 
were labelled by inclusion of [α32P]ATP and analyzed by denaturing PAGE.  All values 
are normalized to 100, representing the yield of wild type T7 RNA polymerase with 
ribonucleotides (rN).  Transcriptions ran for four hours. 
 
Figure 4-10.  Quantitative comparison of T7 RNA polymerase specificity mutants’ 
incorporation of 2′-O-methyladenosine and 2′-O-methylpyrimidines. 
Transcription assay for the incorporation of 2′-O-methyladenosine and 2′-O-
methylpyrimidines (rGmH).  Transcripts were labelled by inclusion of [α32P]GTP and 
analyzed by denaturing PAGE.  All values are normalized to 100, representing the yield 
of wild type T7 RNA polymerase with ribonucleotides (rN).  Transcriptions ran for 20 
hours.   
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Analysis of the ability of the T7 RNA polymerase RGVG-M6 to transcribe heavily-
modified RNA 
After it was demonstrated that RGVG-M6 could catalyze the formation of RNA 
containing up to three 2′-O-methylnucleotides, RGVG-M6 was assayed for its ability to 
generate fully-modified RNA (Figure 4-11).  RGVG-M6 was able to polymerize fully-
modified RNA of two different compositions.   A high yield of 2′-F-purines and 2′-O-
methylpyrimidines (fRmY) was produced, as was a moderate amount of 2′-F-guanosine, 
2′-O-methyladenosine, and 2′-O-methylpyrimidines (fGmH) RNA.  Fully 2′-O-methyl 
RNA (mN) was not obtained.    
 
Figure 4-11.  Transcription of various nucleotide compositions by RGVG-M6. 
Transcription assay for RGVG-M6 catalyzed incorporation of ribonucleotides (rN); 2′-O-
methyluridine (rVmU); 2′-O-methylpyrimidines (rRmY); 2′-O-methyladenosine and 2′-
O-methylpyrimidines (rGmH); 2′-O-methylnucleotides (mN); 2′-F-purines and 2′-O-
methylpyrimidines (fRmY);  and 2′-F-guanosine, 2′-O-methyladenosine, and 2′-O-
methylpyrimidines (fGmH).  Transcripts were analyzed by denaturing PAGE and imaged 
after staining in SYBR-Gold.   Transcriptions ran for 20 hours.  A reaction (10-fold 
diluted) containing wild type T7 RNA polymerase with ribonucleotides (rN) is shown for 
comparison. 
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Previous reports of mN incorporation (Burmeister et al., 2005; Ibach et al., 2013) 
have used more permissive buffer compositions, including manganese as well as rGMP, 
rGTP, or both.  The ability of RGVG-M6 to polymerize mN RNA was tested in several 
such permissive buffers (Figure 4-12).   High yields of RNA were produced in three 
similar buffers containing all four 2′-O-methylnucleotides, namely buffers 8, 9, and 10.  
Buffer 9 contained rGMP and buffer 10 contained rGMP and rGTP and thus cannot be 
said to allow transcription of fully 2′-O-methyl RNA.  Buffer 8 contains manganese, 
yeast inorganic pyrophosphates (YIPP), Triton X-100, and polyethylene glycol (PEG).  It 
also differs from standard transcription buffers in that it contains substantially reduced 
concentrations of spermidine, magnesium, 2′-O-methyl NTPs, template, and polymerase, 
but increased concentration of DTT.  Buffer capacity is provided by HEPES instead of 
Tris.   
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Figure 4-12.  Transcription of 2′-O-methylnucleotides by RGVG-M6 in various 
buffers. 
Transcripts were analyzed by denaturing PAGE and visualized after staining in SYBR-
Gold.   Transcriptions ran for 20 hours.  A reaction containing RGVG-M6 with 
ribonucleotides (rN) is shown for comparison (1).  The composition of each reaction is 
shown. 
The panel of enzymes was tested for mN polymerization in this permissive buffer 
8 (Figure 4-13).  R425C was included in the assay as it was reported to work in a similar 
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buffer with the mN composition.  FA-M5 and FA-M6 show an increase in activity 
relative to the parental FA mutant.  RGVG-M5 and RGVG-M6 and 2P16 are markedly 
improved over the parental RGVG.  RGVG-M5 and RGVG-M6 make the most transcript 
of all variants tested.  As previously observed, R425C appears to be almost completely 
inactive.   
 
Figure 4-13.  Transcription of 2′-O-methylnucleotides (mN) in a permissive buffer. 
Transcription assay for the incorporation of 2′-O-methylnucleotides (mN).  Transcripts 
were analyzed by denaturing PAGE and visualized after staining in SYBR-Gold.   
Transcriptions ran for 20 hours.  A reaction (diluted 10-fold) containing wild type T7 
RNA polymerase with ribonucleotides (rN) is shown for comparison. 
CONCLUSION  
As an evolving (or engineered) protein explores the sequence and fitness 
landscapes, there is an inherent trade-off between activity and stability (Wang et al., 
2002; Tokuriki et al., 2008; Romero and Arnold, 2009; Levin et al., 2009; Soskine and 
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Tawfik, 2010).  As enzyme engineers endeavor to create proteins further removed from 
their wild type parents, they will be confronted by the limitations of the parental protein 
scaffold.  The inclusion of global stabilizing mutations into such a scaffold makes it more 
accommodating to mutations that confer phenotypes of biotechnological importance.  
This may be used as a generalizable tactic for future protein engineering efforts. 
RGVG-M6 is the most effective known enzyme for the polymerization of 2′-
modified RNA.  It is capable of generating transcripts containing 2′-fluoro and/or 2′-O-
methyl NTPs in high yields and is capable of polymerizing nucleic acids consisting 
entirely of modified nucleotides.  This enzyme should prove useful in creating modified 
nucleic acids for in vitro selection (Knudsen et al., 2002; Keefe and Cload, 2008) as well 
as therapeutic uses (Dean and Bennett, 2003; Healy et al., 2004; Wilson and Keefe, 
2006). 
The inclusion of P266L in the assayed mutants only modestly affects the yield of 
full length RNA.  P266L tends to reduce overall RNA yield, but has been associated with 
enhanced promoter clearance and fewer abortive products, especially when suboptimal 
initially transcribed sequences (ITS) are used (Guillerez et al., 2005).  Since premature 
termination, especially in the ITS, is a major problem for unnatural nucleotide 
polymerization, P266L may prove beneficial in certain contexts.  The choice of whether 
to use an M5 or M6 (containing P266L) mutant depends on the DNA template, 
nucleotide composition, and intended use of the RNA product.   
MATERIALS AND METHODS 
Preparation of T7 RNA polymerase variants  
The T7 RNA polymerase coding sequence was cloned into pQE-80L (Qiagen).  
All T7 RNA polymerase variants were derived from this plasmid either by Mega-primer 
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PCR (Bryksin and Matsumura, 2010) or Isothermal assembly (Gibson, 2011). Plasmids 
were transformed into BL21-gold E. coli cells (Agilent). Cells were grown in 2xYT 
media at 37 °C overnight.  Subcultures were grown at 37 °C until reaching OD600 ~0.7-
0.8 at which point 1 mM IPTG was added. Cells were grown for four hours at 37 °C, 
pelleted, and frozen at -80 °C.  Pellets were resuspended in binding buffer (50 mM Tris-
HCl, pH 8.0, 0.5 M NaCl, 5 mM imidazole). Resuspended cells were lysed via sonication 
on ice using 50% probe amplitude for three minutes (1 sec ON, 1 sec OFF). Cell debris 
was pelleted by centrifugation at 10,000 g for 30 minutes. His-tagged T7 RNA 
polymerase was purified by immobilized metal affinity chromatography (IMAC). The 
lysate was run over 1 ml (bead volume) Ni-NTA (Fisher) gravity column pre-equilibrated 
with binding buffer. The column was washed with 10 column volumes of wash buffer (50 
mM Tris-HCl, pH 8.0, 0.5 M NaCl, 20 mM imidazole). T7 RNA polymerase was eluted 
off the column by the addition of three column volumes of elution buffer (50 mM Tris-
HCl, pH 8.0, 0.5 M NaCl, 250 mM imidazole).  Eluted T7 RNA polymerase was dialyzed 
against the final storage buffer (50 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM DDT, 1 
mM EDTA).  Dialates were adjusted to 1 mg/ml and added to an equal volume of 
glycerol (final concentration 0.5 mg/ml). 
In vitro transcription assays 
Real-time transcription reactions contained 40 mM Tris-HCl pH 8.0, 30 mM 
MgCl2, 6 mM spermidine, 6 mM each NTP (or modified NTP), 10 mM DTT, 500 mM 
T7 RNA polymerase, 500 mM DNA template, and 0.17 mg/ml DFHBI (in DMSO) 
(Paige et al., 2011).  Reactions were incubated for up to four hours at 37 °C with Spinach 
fluorescence (Excitation/ Emission 469 nm/501 nm) readings taken every one to four 
minutes in a Safire monochromator (Tecan).   
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Spinach templates were made by thermal cycling overlapping primers (5′-
AATATAATACGACTCACTATAGAGGAGACTGAAATGGTGAAGGACGGGTCCA
GTGCTTCG and 5′-GAAAAGACTAGTTACGGAGCTCACACTCTACTCAACA-
GTGCCGAAGCACTGGACCCG) with Accuprime Pfx DNA polymerase (Life 
Technologies) in its standard buffer (94 °C:2 min, 12 cycles [94 °C:15 sec, 50 °C:30 sec, 
68 °C:30 sec], 68 °C:1 min).  Templates were purified by QIAquick Gel Extraction Kit 
(Qiagen). 
End point transcription reactions contained 40 mM Tris-HCl pH 8.0, 30 mM 
MgCl2, 6 mM spermidine, 6 mM each NTP (or modified NTP), 10 mM DTT, 500 mM 
T7 RNA polymerase, 500 mM DNA template.  Reactions were incubated for four or 20 
hours at 37 °C.  DNA templates were made as above.  rVmU reactions  and rRmY 
reaction were run for four hours, labelled by inclusion of 0.17 µM [α32P]ATP (3000 
Ci/mMol,) and analyzed by denaturing PAGE.  rGmH reactions were run for 20 hours, 
labelled by inclusion of 0.17 µM [α32P]GTP (3000 Ci/mMol,) and analyzed by 
denaturing PAGE.  RGVG-M6 reactions with varied nucleotide composition were run 
twenty hours, incubated for one hour at 37 °C with 0.03 U/µl Baseline-ZERO DNase in 
its supplied buffer, analyzed by denaturing PAGE and visualized after staining in SYBR-
Gold.  The buffer comparison experiment using fully 2′-O-methl NTPs used the buffers 
listed in Figure 4-12, was run for 20 hours, was incubated for one hour 37 °C with 0.03 
U/µl Baseline-ZERO DNase in its supplied buffer, was analyzed by denaturing PAGE 
and was imaged after staining in SYBR-Gold.   
mN in the permissive buffer contained 200 mM HEPES pH 7.5, 5.5 mM MgCl2, 2 
mM spermidine, 0.5 mM each 2′-O-methyl-NTP, 40 mM DTT, 0.01% Triton, 10% 
PEG8000, 1.5 mM MnCl2, 10 U/ml YIPP, 200 nM RNA polymerase, and 200 nM DNA.  
Reactions were run for 20 hours, incubated for one hour at 37 °C with 0.03 U/µl 
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Baseline-ZERO DNase in its supplied buffer, analyzed by denaturing PAGE and 
visualized after staining in SYBR-Gold.   
 32P gels were exposed on a storage phosphor screen (Molecular Dynamics) 
before imaging on a STORM 840 Phosphoimager (GE Healthcare).   Autoradiographs 
were analyzed using ImageQuant (GE Healthcare).  SYBR-Gold gels were directly 
visualized on a STORM 840 Phosphoimager.   
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Chapter 5:  Lessons, ongoing work, and future directions 
The preceding chapters have discussed the evolution and engineering of T7 RNA 
polymerase.  T7 RNA polymerase has been evolved and engineered to alter or enhance 
various characteristics to make it more suitable for biotechnology purposes.  These 
efforts have been undertaken by multiple research groups, each taking different 
approaches.  The wealth of information this has generated allows us to make several 
generalizations regarding the nature of molecular evolution and protein function.  These 
can be applied to a range of research goals and provide lessons to future researchers.   
LESSONS FROM THE EVOLUTION AND ENGINEERING OF T7 RNA POLYMERASE 
Mutation rate and selective advantage 
Most mutations are neutral or slightly deleterious, with a substantial fraction 
being highly deleterious, and beneficial mutations are quite rare (Soskine and Tawfik, 
2010).  Thus, the evolution of new protein function, which often requires the 
accumulation of multiple beneficial mutations, represents a major challenge.   
As was seen in the selections involving the in vitro autogene (Chapter 2), a high 
mutation rate can be quite problematic.  This leaves open the question of what constitutes 
a mutation rate that is too high.  This depends on many factors, but the most important 
one is the rate at which deleterious mutations can be purged from the population.  Simply 
put, if a selection method is capable of purging deleterious mutations from the population 
as fast as they accumulate, then the population can evolve as desired.  There are two ways 
to accomplish this: (1) have a very low mutation rate, such that the few deleterious 
mutations that emerge can be easily purged or (2) have a very powerful selection such 
that mutants free of deleterious mutations can remain a substantial portion of the 
population.  
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A low mutation rate may be the easier path to achieve, but this comes at the 
expense of the chance to make evolutionary jumps in which two or more mutations are 
needed to achieve a new function.  If each individual mutation confers a selective 
advantage, then stepwise evolution is possible, and a very low mutation rate is 
acceptable.  However, it has been shown that the number of pathways allowing stepwise 
evolution can be limited (Weinreich et al., 2006).  If pleiotropy or latent functionality is 
at work, then stepwise evolution may not be possible, and a low mutation rate will not 
suffice.   
A powerful selection can overcome a high mutation rate, and also has benefits 
with regard to specificity (discussed in Chapter 3).  The power of a selection is usually 
discussed in terms of an enrichment factor, or the extent to which a single functional 
mutant in a sea of non-functional mutants can increase its representation in a single 
round.  For example, if a starting population has one functional mutant for each 1000 
non-functional ones before selection, and the functional mutants represent 50% of the 
population after one round of selection, then a 500-fold enrichment factor can be claimed.  
This simple test is a good way to estimate the number of rounds required to find the rare 
active species in a library.  This idea works well in certain contexts; however it 
oversimplifies the idea of a powerful selection.  Enrichment factor as described does not 
attempt to address the dynamic range of a given selection.  That is, can a weakly-active 
variant outcompete a non-functional variant and, more importantly, can a highly-active 
variant outcompete a mediocre variant?  If a selection method does not sufficiently 
reward the best members of a population then the hordes of mediocre mutants will 
dominate the population.  This can lead either to the evolution of mediocre enzymes or to 
the catastrophic collapse of the population, depending on the mutation rate.   
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Activity and specificity 
A powerful selection method that is able to reward the most active mutants has 
additional benefits with respect to specificity (Khersonsky and Tawfik, 2010).  An 
evolving enzyme faces trade-offs between its new function and its old function.  There 
are documented cases in which the acquisition of a new specificity comes with a sharp 
decrease in the ancestral activity (strong negative trade-off) (Vick and Gerlt, 2007; 
McLoughlin and Copley, 2008).  However, the vast majority of experiments point to a 
weak negative trade-off in which a large increase in the new activity comes with a 
modest reduction in the old activity (Matsumura and Ellington, 2001; Aharoni et al., 
2005; Khersonsky and Tawfik, 2010; Tokuriki et al., 2012).  Either model suggests that 
as the new function is enhanced, the old function diminishes (Figure 5-1).  Therefore a 
selection that allows the most active mutants to outcompete moderately active ones will 
encourage the evolution of specificity.   
 
Figure 5-1.  Activity and specialization.  
During the evolution of a new substrate specificity, an enzyme will lose its ancestral 
function.   In the weak negative trade-off model (red), a large increase in new function is 
coupled to a weak decrease in old function, resulting in a moderately active generalist. In 
the strong negative trade-off model (blue) a small increase in the new activity results a 
large decrease in ancestral activity.  This figure is inspired by a review of enzyme 
promiscuity (Khersonsky and Tawfik, 2010). 
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Previous efforts in evolving T7 RNA polymerase, and the efforts outlined in 
Chapter 3 illustrate this point.  The RNA polymerase promoter specificity variants 
evolved by phage-assisted continuous evolution (PACE) were never subject to strong 
selective pressure at the higher ends of activity.  This allowed mediocre, generalist 
polymerases to dominate the population (Dickinson et al., 2013).  It should be noted the 
emergence of a weak generalist phenotype was accompanied by an increase in expression 
(caused by mutations to the RBS).  This accords with previous observations that strong 
negative trade-offs are often accompanied by gene duplication or promoter and RBS 
strengthening (McLoughlin and Copley, 2008; Khersonsky and Tawfik, 2010).   
In contrast, T7 RNA polymerase promoter specificity variants evolved by 
compartmentalized partnered replication (CPR) were subject to powerful selection 
pressures at the higher ends of activity, and consequently evolved to be both highly active 
and specific.  There are, of course, limits to this model, as the most active polymerases in 
Chapter 3 were similar to, but not exactly the same as, the most specific ones.   
Assay conditions 
As can be seen in Table 3-2, the reported and observed activity of T7 RNA 
polymerases mutants can vary widely.  This is due in part to inappropriate assay 
conditions.  In one instance the wild type reference is mutated, resulting in reduced 
activity, thus increasing the apparent activity of the mutants to which it is compared 
(Temme et al., 2012).  A more common problem is drastically overexpressing T7 RNA 
polymerase and allowing it to overexpress a reporter.  This causes an enormous burden 
on cells, resulting in lower protein yield, mutation, and cell death.  This has led to reports 
that the wild type T7 RNA polymerase:promoter pair is among the weakest pairs tested 
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(Shis and Bennett, 2013) and to erroneous reports of enzymes with activities many-fold 
greater than wild type T7 RNA polymerase (Esvelt et al., 2011). 
In one case, the promoter and RBS driving an evolving T7 RNA polymerase was 
allowed to evolve, and this evolved promoter and RBS was retained in the subsequent 
assays (Dickinson et al., 2013).  This confuses the function per enzyme with the relative 
abundance of protein.  This highlights a more fundamental issue, namely, that the 
verification of the activity of an evolved enzyme should not mimic the selection 
conditions.  As the adage that “you get what you select for” implies, an evolved enzyme 
might not have the exact desired functionality, but may be an artifact of the selection.  An 
assay that mimics the selection conditions may miss subtle differences in the evolved and 
desired function.  When possible, in vivo evolved enzymes should be assayed in vitro and 
vice versa. 
Activity and stability 
An estimated 40% of mutations are highly or weakly deleterious, with the 
majority of their effects being due to a reduction in folding or stability (Camps et al., 
2007; Soskine and Tawfik, 2010).  Mutations that confer a new functionality tend to 
exhibit even stronger destabilizing effects (Wang et al., 2002; Tokuriki et al., 2008; 
Levin et al., 2009; Soskine and Tawfik, 2010).  Thus, compensatory mutations are 
needed to allow a potentially adaptive, but destabilizing mutation to emerge.  The ability 
of the M5 stabilizing mutations to unlock the substrate expanding potential of the FA and 
RGVG mutations underscores this point.  Going forward, selections for new function 
may benefit from the addition of global stabilizing mutations (if any are known) or by 
starting with an intense neutral drift, discussed below. 
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ONGOING WORK AND FUTURE DIRECTIONS 
A neutral network of T7 RNA polymerases 
As natural proteins have evolved over millions of years, there has been a trade-off 
between robustness to mutation and evolvability.  The degree to which a protein retains 
its character in the face of mutation is likely an evolved phenotype dependent on the 
mutation rate and selective pressure it has faced over evolutionary time.  However, 
robustness and evolvability do not necessarily have to be antagonistic on a population 
level, as a neutral network of robust mutants can be quite evolvable (Wagner, 2008; 
Payne and Wagner, 2014).   
About 8% of mutations ablate activity and another 30% reduce activity (Camps et 
al., 2007; Soskine and Tawfik, 2010).  Most of the mutations appear neutral, with a small 
percentage being beneficial.  This makes selecting for new functionality problematic, 
especially if multiple beneficial mutations are required.  Mutating a library to the point 
where there is a reasonable chance of a single variant having multiple beneficial 
mutations all but assures that each variant will have many deleterious mutations.  This 
problem can be overcome by purging deleterious mutations with iterative rounds of 
purifying selection (Bershtein et al., 2006, 2008).  This method, termed “neutral drift” 
entails repeatedly selecting for wild-type function within a highly mutagenic regime.  
Each round, new mutations are introduced into the population, and the population is 
subject to a purifying selection.  Since only active variants survive, all highly deleterious 
mutations are necessarily purged from the population.  A selection (like CPR) that 
enriches for highly active variants also purges mildly deleterious mutations to a lesser 
extent.  After many such cycles, neutral and beneficial mutations can accumulate.  The 
resulting neutral network is a highly diverse library that (1) may contain stabilizing 
mutations and (2) may contain mutations with latent potential to confer a new function.   
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As the mutations accumulate in a neutral drift selection, mildly destabilizing 
mutations begin to pile up.  Thus, any mutation that can broadly compensate for the 
destabilizing effects of other mutations will be selected for.   Thus, a persistent neutral 
drift selection can be expected to favor the accumulation of global stabilizing mutations 
(Bershtein et al., 2006, 2008; Soskine and Tawfik, 2010; Goldsmith and Tawfik, 2009).  
It should be noted that while stabilizing mutations should accumulate, destabilizing 
mutations are much more common.  It should therefore not be expected that each 
individual variants is more stable than wild type, although many may be (Bershtein et al., 
2008). 
The neutral drift population should not only contain mutations conferring 
robustness, but also mutations conferring latent functionality.  Essentially, selecting for 
wild-type function allows for the accumulation of mutations that appear neutral in that 
context.  When the selective pressure changes, a subset of the previously neutral 
mutations can confer an advantage in the new context (Amitai et al., 2007; Gupta and 
Tawfik, 2008).   
This framework was applied to the creation of a neutral network of T7 RNA 
polymerase variants.  Initially, wild type T7 RNA polymerase was amplified by error-
prone PCR, adding an expected one to two mutations per gene.  The resulting library was 
subject to selection by CPR, essentially as described in Chapter 3 (Figure 5-2).  
However, unlike the selection for promoter utilization, the entire open reading frame was 
allowed to evolve.  A PCR product spanning the entire open reading frame could not be 
efficiently captured on a bead, so a new recovery method was devised.  Essentially, the 
emulsion PCR step used primers that appended a novel sequence tag.  When the emulsion 
was broken, all DNA was recovered (including input plasmid) with a PCR-cleanup 
column.  A second PCR step was performed, in which primers annealed to the recently 
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appended tags.  The product was gel purified and used as the input for a third PCR with 
nested primers.  This third PCR helped reduce the accumulation of shorter amplicons.  
This PCR product was gel purified, digested, and ligated into an expression vector, thus 
preparing it for further cycles.   
 
Figure 5-2.  Compartmentalized partnered replication selection scheme. 
Error-prone PCR was performed before Rounds 4, 7, 9 and 14, and 17 (Table 5-
1).  The error-prone PCR before Round 17 was not the traditional protocol involving Taq 
DNA polymerase and manganese (Fromant et al., 1995).  Instead, it was essentially a 
“normal” PCR using a newly evolved polymerase termed A12 DNA polymerase.  A12 
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DNA polymerase is a shuffled chimera of KOD and Pfu DNA polymerases that was 
evolved by Dan Garry and screened by Tom Wall of the Ellington Lab.  A12 DNA 
polymerase is extremely fast and synthesizes large quantities of product, but is highly 
error-prone.  A12 was therefore found to be suitable for facile mutagenesis between 
rounds.   
 
Table 5-1.  Conditions used in neutral drift experiments. 
As rounds progressed, the stringency was increased and the protocol was 
improved.  In Rounds 1 to 11, T7 RNA polymerase was driven by the strong T5-lac 
promoter.  Rounds 1 to 8 were strongly induced with 0.5 mM IPTG while Rounds 9 to 11 
were moderately induced with 0.1 mM IPTG.  In Rounds 12 to 17, T7 RNA polymerase 
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was driven by the moderate lacUV5 promoter.  Round 12 was strongly induced with 0.5 
mM IPTG while Rounds 13 to 17 were moderately induced with 0.05 mM IPTG.    
After Round 15, CPR was performed under the “CPR Nuevo” conditions.  In CPR 
Nuevo, developed by Michael Ledbetter of the Ellington Lab, the water-in-oil 
emulsification is performed in a TissueLyser LT at 42 Hz for four minutes.  Agitation is 
aided by the inclusion of the rubber piston from a 1 ml syringe.  These conditions have 
been shown to create more consistent emulsions with only one bacterium per droplet.   
Additionally, after Round 15, Taq DNA polymerase was replaced with PK6 DNA 
polymerase.  PK6 DNA polymerase is a shuffled chimera of KOD and Pfu DNA 
polymerases that was evolved and screened by Dan Garry of the Ellington Lab.  Similarly 
to A12 DNA polymerase, PK6 DNA polymerase is extremely fast and generates vast 
quantities of product.  It allowed for greater recovery and less short-amplicon 
accumulation, enabling a larger library to be transformed each round. 
The Round 17 library was transformed into a pCTC-Y2 reporter line (described 
below).  Of 186 clones assayed, the 21 most active variants, judged by T7 RNA 
polymerase driven fluorescence output, were sequenced.  The population was heavily 
mutated, ranging from 16 to 33 mutations each.  On average each variant possessed 23.4 
mutations or 8.8 mutations per kilobase.  Of these, 38.5% were non-synonymous, 
resulting in 9.0 coding mutations per gene.  Surprisingly only three mutations occurred in 
more than 10% of genes.  R31H, E108K, and D130V occurred three, three, and four 
times respectively.  Of the M5 mutations, S430P and S633P each occurred once.   
This neutral drift library is heavily mutated and may serve as a potential starting 
point for several directed evolution efforts.  Processivity and thermal stability are 
examples of phenotypes for which a diverse neutral network is an ideal starting library.  
The neutral drift library may also be continued further in hopes that more consensus 
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mutations emerge.  The resulting mutations may be applied to RGVG or another substrate 
specificity mutant (Chapter 4) in an effort to increase its activity. 
T7 RNA polymerase processivity 
T7 RNA polymerase undergoes a large conformational change as it moves from 
initiation to elongation.  In the initiation phase, it makes contact with the promoter 
upstream of the active site and feeds the template strand into the active site.  In the 
elongation phase, it no longer make contact with upstream DNA, but instead makes 
contact with downstream DNA and funnels the downstream template strand into the 
active site.  The fingers and N-terminal domain make long-range electrostatic interaction 
with this DNA and likely contribute to the processivity of the polymerase (Tahirov et al., 
2002).  There is little known about the specific residues involved in the processivity of T7 
RNA polymerase.   
Processivity is likely a distributed phenotype so a targeted mutagenesis library 
would not be effective for efforts to enhance to processivity of T7 RNA polymerase.  
Similarly, several mutations are likely required to see a noticeable increase in 
processivity, so a random mutagenesis library would likely not be ideal.  Thus, the 
neutral drift library described above was chosen as a starting point for the evolution of a 
hyper-processive T7 RNA polymerase mutant.   
Directed evolution by CPR as above was continued, starting with the Round 16 
population (Table 5-2).  However, in order to add selective pressure for processivity a 
long 5′ UTR was included in the mRNA transcribed by T7 RNA polymerase.  Thus, in 
order to make PK6 DNA polymerase (which catalyzes the emulsion PCR) T7 RNA 
polymerase would need to make a roughly 6-kb transcript, as opposed to the 2.5-kb 
mRNA previously required.   
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Table 5-2.  Conditions used in the selection for processivity.  
In order to determine the effectiveness of such a spacer, a construct (pC1Y2) was 
made in which the T7 promoter was followed by eCFP immediately followed by seYFP 
(Figure 5-3).  The two fluorescent proteins used different sets of codons to minimize the 
possibility of recombination.  eCFP used “version 1” codons and is shorthanded as C1, 
seYFP used “version 2” codons and is shorthanded as Y2.  A similar construct (pC1-
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RCT-Y2) was made in which C1 and Y2 were separated by a roughly 2.5-kb spacer 
comprising the reverse complement of a null-mutant of Taq DNA polymerase (RCT).   
 
Figure 5-3.  5′ UTR length and protein yield.  
Wild type T7 RNA polymerase was transformed into two reporter lines.  In the first 
(pC1Y2), a T7 promoter is followed by eCFP and seYFP.  In the second, eCFP and 
seYFP are separated by a 2.5-kb spacer.   The eCFP and seYFP fluorescence (in Relative 
Fluorescence Units) / OD600 from the first construct were defined as 100 and compared 
to reading from the second construct.  Values are the average from three independent 
cultures; error bars represent standard error. 
Wild type T7 RNA polymerase and an inactive T7 RNA polymerase were 
transformed into cell lines containing pC1Y2 and pC1-RCT-Y2.  The inactive control 
indicated that there were no cryptic promoters in the spacer sequence and that seYFP was 
only being driven from the T7 promoter.  The eCFP and seYFP outputs from wild type 
T7 RNA polymerase with pC1Y2 were each defined as 100.  These outputs were 
compared to the eCFP and seYFP outputs of wild type T7 RNA polymerase with pC1-
RCT-Y2.  As expected the eCFP output was similar for each construct, and the addition 
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of the 2.5-kb spacer reduced seYFP yield about five-fold.  Thus the spacer was effective 
and could serve as the basis for selection.   
A construct (pC1-RCT-PK6) was designed in which the T7 promoter was 
followed by a roughly 3.5-kb spacer, consisting of C1 and RCT, followed by PK6 DNA 
polymerase.  The Round 16 neutral drift library was transformed into a cell line 
containing this construct and subjected to two rounds of selection by CPR, with A12 
DNA polymerase-based error-prone PCR between rounds (Table 5-2). 
The Round 18 population was transformed into the pC1-RCT-Y2 reporter line 
and 93 clones were assayed for eCFP and seYFP.  11 clones showed activity comparable 
to wild type T7 RNA polymerase and were sequenced. These clones ranged from 20 to 
32 mutations, averaging 26.5 mutations per gene (10.0 mutations per kilobase).  43.0% of 
mutations were non-synonymous, resulting in an average of 11.4 coding mutations per 
gene.  Of the 11 mutants, seven contained the mutation D130V, while the H161Y 
mutation was observed in three mutants.   
The preponderance of mutations and the emergence possible consensus mutations 
suggested that gene shuffling was in order.  The Round 19 population was shuffled 
amongst itself (Stemmer, 1994; Meyer et al., 2014), and two additional rounds of 
selection were performed.    
The Round 21 population was assayed as before, except a new reporter construct 
(pCTC-Y2) was used.  pCTC-Y2 contains the T7 promoter followed by C1, RCT, the 
reverse complement of the Cas9 gene, and Y2.  In this case, seYFP was only made if a 
greater than 8-kb transcript was made.  93 clones from Round 21 were assayed, seven 
showed levels comparable to wild type and were sequenced.  These ranged from 26 to 39 
mutations each and averaged 33.4 mutations each (12.6 mutations per kilobase).  40.5% 
of the mutations were non-synonymous, resulting in 13.6 non-synonymous mutations per 
 149 
gene.  Three mutants contained the D130V mutation.  One mutant from Round 21 was 
able to produce about 60% more seYFP than wild type T7 RNA polymerase (requiring an 
8-kb transcript) despite having only been selected for the ability to generate 6-kb 
transcripts.   
To increase the selective pressure for processivity, a new construct (pCTC-PK6) 
was made in which the seYFP from the pCTC-Y2 reporter was replaced with PK6 DNA 
polymerase.  Four additional rounds were performed with this new construct, which 
required more than 10-kb of transcription to yield PK6 DNA polymerase.  The PCR steps 
between rounds were performed with Accuprime Pfx DNA polymerase instead of the 
error-prone A12 DNA polymerase and gene shuffling was performed prior to Round 24.  
These actions were performed in order to allow deleterious mutations to be purged and 
beneficial mutations to be combined.  186 clones from the Round 25 population were 
assayed using the pCTC-Y2 line as described previously.  The eCFP and seYFP output 
(normalized to OD600) for the 39 most active clones are shown in (Figure 5-4).  Several 
mutant are able to make considerably more seYFP (requiring an 8-kb transcript) than 
wild type T7 RNA polymerase.   
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Figure 5-4 
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Figure 5-4.  In vivo activity assay of Round 25 of the T7 RNA polymerase selection 
for processivity.  
The library from Round 25 of the selection for processivity was transformed into the 
pCTC-Y2 reporter plasmid.  The eCFP and seYFP fluorescence (in Relative Fluorescence 
Units) / OD600 is a measure of 1-kb and 8-kb mRNA output, respectively.  The 
fluorescence outputs from eCFP and seYFP driven by wild type T7 RNA polymerase are 
each defined as 100.  The 39 most active clones out of 186 tested are shown.   
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37 clones were sequenced and they contain 24 to 49 mutations.  They averaged 
36.6 mutations per gene, 13.8 per kilobase.  40.1% of mutations were non-synonymous, 
resulting in 14.7 coding mutations per gene.  R52H, E63V, V134I, and Q169R each 
occurred five times, H772R occurred seven times, and D130V was present in 26 of 37 
mutants.  It is not immediately apparent whether these mutations directly increase 
processivity, or merely improve stability.  The most common mutation, D130V, was seen 
frequently in Round 17, before the selection for processivity began.  The next most 
common mutation, H772R, has been shown to confer stability to the G542V H784S 
mutant (Chapter 4).  It is possible that the selection for processivity is merely a very 
stringent selection for activity.  More selection, more precise analysis of the selected 
mutants, and isolation of the effects of each consensus mutation is required.   
Thermal stability  
Pooling the sequence data from Rounds 17, 18, 21, and 25 described above, it is 
easier to see the emergence of several consensus mutations.  Three mutations occur in at 
least 10% of the 77 mutants from these rounds.  Specifically, D130V occurs in 40 
mutants, H161Y occurs in 11 mutants, and H772R occurs in eight mutants.  These 
mutations all arose before selection for processivity, so they may be conferring 
robustness to mutation.  They can be added to the substrate specificity mutants described 
in Chapter 4 to enhance their activity, or serve as the basis for a selection for thermal 
stability.   
There may already be enough information gathered to design a thermostable T7 
RNA polymerase mutant.  The M5 mutations (S430P, N433T, S633P, F849I, F880Y) and 
the mutations described in this chapter may be added in some combination to generate a 
more thermostable mutant.   
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Alternatively, a direct selection for thermal stability may be required.  The CPR 
selection as described is not compatible with a direct selection for thermal stability. This 
is because T7 RNA polymerase performs its function in E. coli, whose temperature range 
is limited.  This problem may be overcome by either adapting the selection to a 
thermostable organism or by altering the selection method.   
In order to select for a function not compatible with E. coli function (i.e. thermal 
stability or unnatural nucleotide incorporation), T7 RNA polymerase must perform its 
function outside of the cell.  In such a selection, the host cell would function only to 
produce T7 RNA polymerase.  The cell would then be emulsified and lysed, allowing T7 
RNA polymerase to access the emulsion compartment and perform a function that would 
allow its genotype to succeed.  This could take the form of an autogene like selection in 
which T7 RNA polymerase transcribes its own genetic information.  Alternatively, T7 
RNA polymerase could transcribe an oligonucleotide that can be used to capture the 
plasmid encoding it.  This would be analogous to, but quite distinct from, 
compartmentalized self-tagging (CST) (Pinheiro et al., 2012).  Other schemes can be 
envisioned in which T7 RNA polymerase makes or activates primers used by a DNA 
polymerase to amplify the T7 RNA polymerase gene.   
CONCLUDING REMARKS 
T7 RNA polymerase remains a fascinating and useful enzyme.  It has been 
engineered and evolved by several labs over the past few decades.  In this work, these 
previous engineering efforts have been built upon, and some of the most active and 
potentially useful mutants to date have been generated.  The methods, challenges, and 
successes presented herein can hopefully provide valuable instruction to future protein 
engineers. 
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MATERIALS AND METHODS 
Compartmentalized partnered replication 
Libraries (~50 ng purified ligation) were transformed into BL21 gold cells 
(Agilent) containing the target selection plasmid.  Library DNA was introduced by 
electroporation using 0.2 cm cuvettes at 2.5 kV in an E. coli pulser (BioRad).  This 
routinely resulted in roughly 107 CFUs (multiple replicates were often pooled).   
100 μl overnight cultures from the transformation were subcultured in 2 ml 2xYT 
medium, grown for one hour (OD600 ~0.6) and induced with IPTG at 37 °C for four 
hours.  200 μl of the induced culture was centrifuged at 5,000 g for 10 minutes to pellet 
the cells.  The supernatant was removed and cells were gently resuspended in 20 μl 10x 
PCR buffer (500 mM KCl, 100 mM Tris-HCl pH 8.3, 15 mM MgCl2) 10 μl dNTP mix (4 
mM each), 4 μl each primer (20 μM), and 162 μl water.  Emulsification was performed 
by slowly adding resuspended cells to 600 μl of spinning oil mix (438 μl Tegosoft DEC 
(Evonik), 42 μl AbilWE09 (Evonik), and 120 μl Mineral oil (Sigma)).  
In “CPR classic” the oil mixture was constantly spun in a tube (Sarstedt 13 ml 95 
mm x 16.8 mm) on ice using a stirbar (Spinplus 9.5 mm x 9.5 mm Teflon, Bel-Art) on a 
magnetic plate (Corning) at the maximum setting (1150 rpm). The cell mixture was 
slowly added over a one minute interval and spun for an additional four minutes.  
In “CPR nuevo” the oil and cell mixtures were combined in 2 ml centrifuge tube, 
along with the rubber piston from a 1 ml syringe.  The tube was then agitated at 42 Hz for 
four minutes in a TissueLyser LT (Qiagen). 
The emulsified cells were thermal cycled (95 °C:3 min, 20 cycles [95 °C:30 sec, 
55 °C:30 sec, 72 °C:5 min], 72 °C:5 min) such that cells containing the most active 
enzymes will also contain the most DNA polymerase and will preferentially amplify.  
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The emulsion was broken in two steps. Firstly, it was centrifuged at 10,000 g for 
five minutes and the oil (upper) phase was removed. Secondly, 300 μl of bead buffer (0.2 
M NaCl, 10 mM Tris-HCl pH 7.4, 1 mM EDTA, 0.1% Tween-20) and 500 μl chloroform 
was added and the mixture was vortexed vigorously. The mixture was transferred to a 
heavy-gel phase-lock tube (5 Prime) and upon centrifugation at 16,000 g for two minutes 
the aqueous (upper) phase was collected along with any nucleic acids present.  This was 
purified using SV Wizard PCR clean-up (Promega).   
To facilitate purification of the DNA amplified by in the emulsion PCR step, 
primers that append sequence tags to the ends of each amplicon were used.  Purified 
DNA was used as the template for re-amplification using primers that anneal to the 
appended tags.  This PCR product was gel purified and used as the template in another 
PCR step using nested primers.  This was purified and followed by digestion and ligation 
into the appropriate plasmid backbone. 
Error-prone PCR 
The error-prone PCR reaction mixture was composed of 50 mM KCl, 10 mM Tris-HCl 
pH 8.3, 2.5 mM MgCl2, 5 μg/ml BSA, 0.35 mM dATP, 0.4 mM dCTP, 0.2 mM dGTP, 
1.35 mM dTTP, 0.5 mM MnCl2, 0.5 μM each primer, 2 ng/μl template, and 0.8 U/μl Taq 
DNA polymerase (New England Biolabs) and was thermal cycled (95 °C:4 min, 25 
cycles [95 °C:30 sec, 55 °C:30 sec, 72 °C:5 min], 72 °C:5 min).   This achieved the 
expected one mutation per 500 base pairs. 
Gene shuffling 
To shuffle CPR libraries, DNA was digested, thermal cycled, and amplified.  
First, 4 µg DNA was mixed with 5 µl 1M Tris-HCl pH 7.4, 5 µl 200 mM MnCl2, and 
water up to 100 µl.  This mixture was incubated at 15 °C for five minutes.  One unit of 
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DNAse (New England Biolabs) was added and the mixture was incubated at 15 °C for 
three minutes before heat inactivating at 80 °C for five minutes.   Digested DNA was 
purified using SV Wizard PCR clean-up (Promega).   
20% of the recovered fragments were added to Platinum Taq DNA polymerase 
High Fidelity (Life Technologies) in its normal reaction buffer with no primers (100 µl 
total).  This was thermal cycled as follows: 94˚C:2 min; 35 cycles of (94˚C:30 sec, 
65˚C:90 sec, 62˚C:90 sec, 59˚C:90 sec, 56˚C:90 sec, 53˚C:90 sec, 50˚C:90 sec, 47˚C:90 
sec, 44˚C:90 sec, 41˚C:90 sec, 68˚C:4 min); 68˚C:4 min.  The reassembled fragments 
were purified using SV Wizard PCR clean-up (Promega).  This was used as a template 
for PCR and prepared normally for the next round of CPR.     
In vivo activity assay 
T7 RNA polymerase plasmids or libraries were electroporated into BL21-gold 
cells containing pC1Y2, pC1RCT-Y2, or pCTC-Y2 in which the T7 promoter variants 
controlled expression of eCFP and seYFP.  Single colonies were grown at 37 °C 
overnight.  100 μl of the culture was grown in 2 ml 2xYT medium at 37 °C for one hour 
(OD600 ~0.6) and induced with 0.05 mM IPTG for four hours.  This concentration of 
IPTG was chosen in order to limit metabolic overload on the host and prevent saturation 
of signal.  After induction, cells were centrifuged and resuspended in 600 µl PBS.  200 µl 
of resuspended cells were measured for OD600 on a Synergy-HT plate reader (Bio-Tek) 
and eCFP fluorescence (Excitation/ Emission 434 nm /474 nm) and seYFP fluorescence 
(Excitation/ Emission 485 nm/535 nm) on a Safire monochromator (Tecan).   
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